Secondary and unspecified malignant neoplasm of lymph nodes

C3_LYMPHNODES_SECONDARY_NAS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Cause of death: ICD-10 — C77 Cause of death: ICD-8 — 196 Cancer registry: Topography ICD-O-3 — C77 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 3 2 out of 7 registries used, show all original rules.	4038
4. Check minimum number of events None	4038
5. Include endpoints None	4038
6. Filter based on genotype QC (FinnGen only)	3577

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF9

NAME	C3_LYMPHNODES_SECONDARY_NAS
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C77
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	196
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C77
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Secondary and unspecified malignant neoplasm of lymph nodes based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3577	1607	1970
Unadjusted period prevalence (%)	0.75	0.57	0.90
Median age at first event (years)	63.19	61.70	64.41

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3697: Matched controls
36970

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

WF049

NOMESCO Finland

Radiotherapy of metastasis

852.8

322.8

313

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

22.5

312.1

231

109

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

3092.6

310.6

296

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

107.5

307.7

260

A04AA01

ATC

ondansetron; systemic, rectal

31.6

307.7

1020

440

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

4061.9

307.7

377

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

55.8

307.7

1175

306

WZC00

NOMESCO Finland

Treatment plan or consultation

4.1

307.7

1848

7273

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

21.8

307.7

586

317

A03FA01

ATC

metoclopramide; systemic, rectal

19.7

307.7

2103

2323

C82.1

ICD-10 Finland

Follicular lymphoma grade II

7982.9

307.7

669

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

238.9

307.7

890

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

792.5

307.7

543

A49.9

ICD-10 Finland

Bacterial infection, unspecified

5.1

307.7

890

2158

JN4AD

NOMESCO Finland

Body CT examination

14.1

307.7

1154

1156

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

8.3

307.7

623

878

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

61.9

307.7

243

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

5053.6

307.7

1118

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

10.5

307.7

511

554

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

307.7

365

H02AB02

ATC

dexamethasone; systemic

67.1

307.7

891

174

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

307.7

1108

XX3DW

NOMESCO Finland

Time consuming IT work

10.0

307.7

631

746

XW000

NOMESCO Finland

Bone marrow biopsy

38.0

307.7

1024

369

ZX120

NOMESCO Finland

Intravenous

7.4

307.7

756

1241

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

210.5

307.7

291

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

+∞

307.7

516

L03AA02

ATC

filgrastim; parenteral

1306.4

307.7

1035

ZX112

NOMESCO Finland

Subcutaneous

30.4

307.7

250

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

1356.7

307.7

574

PJA10

NOMESCO Finland

Exploration of lymph nodes

171.8

307.7

675

WW500

NOMESCO Finland

Blood transfusion

24.1

307.7

574

280

A04AA02

ATC

granisetron; systemic, transdermal

954.8

307.7

759

Z51.5

ICD-10 Finland

Palliative care

9.7

307.7

620

749

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

155.7

307.7

192

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

67.8

307.7

288

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

307.7

454

D70.82

ICD-10 Finland

Drug-induced neutropenia

103.1

307.7

303

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

+∞

307.7

473

R59.9

ICD-10 Finland

Enlarged lymph nodes, unspecified

51.6

307.7

368

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

259.2

307.7

287

WF003

NOMESCO Finland

Adjuvant radiotherapy

1182.0

307.7

324

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

1198.0

307.7

328

M04AA01

ATC

allopurinol; systemic

8.5

307.7

1617

3109

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

115.8

307.7

218

L03AA13

ATC

pegfilgrastim; parenteral

5203.3

307.7

838

EP1AE

NOMESCO Finland

Neck ultrasound examination

10.9

307.7

595

638

JN4BD

NOMESCO Finland

Extensive body CT

25.2

307.7

1332

809

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

82.8

307.7

667

1XC02, ,

NOMESCO Finland

73.3

307.7

272

JN6AD

NOMESCO Finland

CT of torso and neck

116.0

307.7

659

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

247.9

307.7

338

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

1547.3

307.7

839

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

4657.5

307.7

2647

WF002

NOMESCO Finland

Radical radiotherapy

171.5

307.7

452

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

+∞

306.6

290

9680/3-C77.8

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions

+∞

297.0

281

N02AA05

ATC

oxycodone; systemic

4.1

294.9

1046

3251

C82.2

ICD-10 Finland

Follicular lymphoma grade III, unspecified

+∞

290.5

275

R50.9

ICD-10 Finland

Fever, unspecified

4.2

290.3

991

2993

130

Kela drug reimbursment

Malignant tumour

+∞

286.2

271

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

+∞

285.2

270

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

2791.2

282.8

270

H02AB06

ATC

prednisolone; systemic

3.4

280.7

2397

12891

C61

ICD-10 Finland

Malignant neoplasm of prostate

492.2

278.9

275

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

+∞

272.3

258

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

4.2

269.5

865

2486

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

268.0

254

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

267.0

253

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

260.5

247

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

252.0

239

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

33.4

249.6

160

JN4CD

NOMESCO Finland

Very extensive body CT

13.9

248.4

234

179

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

247.7

235

Z85.7

ICD-10 Finland

Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues

+∞

246.7

234

A04AA55

ATC

palonosetron, combinations; systemic

+∞

245.6

233

9691/3-C77.9

ICD-O-3

Follicular lymphoma, grade 2 of lymph node, NOS

+∞

234.9

223

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

7.0

233.9

378

592

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

233.9

222

TPX10

NOMESCO Finland

Implantation of vascular injection port

10.5

232.9

265

271

C82.00

ICD-10 Finland

Follicular nodular non-Hodgkin's lymphoma, ungraded

+∞

230.7

219

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

32.8

229.6

148

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

63.0

220.6

122

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.0

220.2

2295

13127

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

52.1

219.8

126

C81.0

ICD-10 Finland

Nodular lymphocyte predominant Hodgkin lymphoma

+∞

213.6

203

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

2024.4

210.3

202

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

365.8

209.1

209

PJA12

NOMESCO Finland

Sentinel node biopsy

1066.8

208.3

202

WZC30

NOMESCO Finland

Teaching

3.6

203.5

815

2688

WF004

NOMESCO Finland

Palliative radiotherapy

1947.2

202.9

195

212

Kela drug reimbursment

Gout

9.2

202.0

252

291

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

8.9

196.1

252

302

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

88.3

195.7

103

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

5.2

193.2

436

935

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

189.2

180

115

Kela drug reimbursment

Breast cancer

+∞

178.6

170

JN5JR

NOMESCO Finland

Extensive PET-CT of upper body metabolism (eyebrows to thighs)

81.2

178.5

L02AE02

ATC

leuprorelin; implant, parenteral

24.8

176.8

125

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

24.2

173.6

124

D70.89

ICD-10 Finland

Neutropenic splenomegaly

17.7

167.5

137

9663/3-C77.9

ICD-O-3

Hodgkin lymphoma, nodular sclerosis, NOS, of lymph node, NOS

+∞

163.8

156

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

15.5

162.8

143

C81.7

ICD-10 Finland

Other classical Hodgkin lymphoma

+∞

160.6

153

J05AB11

ATC

valaciclovir; oral

3.1

158.9

789

2934

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

7.5

158.4

234

330

C81.2

ICD-10 Finland

Mixed cellularity classical Hodgkin lymphoma

+∞

154.2

147

A02BC02

ATC

pantoprazole; systemic

2.8

153.1

2823

19857

H02AB07

ATC

prednisone; oral

3.1

152.7

766

2860

116

Kela drug reimbursment

Prostate cancer

+∞

147.9

141

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

11.4

147.1

155

141

J01MA12

ATC

levofloxacin; systemic

2.8

143.8

927

3957

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

1422.7

140.5

136

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

6.3

138.1

241

405

WW300

NOMESCO Finland

Transfer of autologic stem cells

698.7

137.7

135

HA1AA

NOMESCO Finland

X-ray mammography

5.9

137.4

257

462

WX408

NOMESCO Finland

General anesthesy, balanced

2.6

137.2

1073

5030

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

8.4

136.8

181

224

9823/3-C77.9

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph node, NOS

+∞

136.3

130

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

460.9

135.0

134

ZX070

NOMESCO Finland

Intensity modified radiotherapy

460.9

135.0

134

NEA10

NOMESCO Finland

Exploration of soft tissue of pelvis, percutaneous

32.6

133.4

TGC00

NOMESCO Finland

Bronchial lavation

6.3

131.7

229

383

ZX090

NOMESCO Finland

Other technic of radiotherapy

177.8

131.4

137

A04AD12

ATC

aprepitant; systemic

655.6

129.3

127

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

3.3

127.8

550

1862

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

1271.0

126.8

123

B01AB10

ATC

tinzaparin; parenteral

3.5

124.0

485

1545

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

123.6

118

D47.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified

51.7

123.5

L02BA01

ATC

tamoxifen; oral

63.0

122.7

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

19.7

121.0

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

118.4

113

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

66.1

118.2

9591/3-C77.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS

+∞

117.3

112

TPX15

NOMESCO Finland

Removal of vascular injection port

40.2

116.7

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

28.4

115.9

B01AB05

ATC

enoxaparin; parenteral

2.3

113.7

1266

6858

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

174.1

113.0

118

WX402

NOMESCO Finland

General anaesthesia

2.5

111.6

870

4022

XX9CD

NOMESCO Finland

Very extensive complementary CT

+∞

111.0

106

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

110.6

972

4745

ZX108

NOMESCO Finland

Inhalation

16.4

109.8

9690/3-C77.9

ICD-O-3

Follicular lymphoma, NOS, of lymph node, NOS

+∞

108.9

104

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

107.8

103

9663/3-C77.8

ICD-O-3

Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of multiple regions

+∞

107.8

103

4701

FHL

Neck lymph node removal

61.0

107.6

D38.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Mediastinum

28.9

106.1

B72

ICPC

Hodgkin Lymphoma

1058.1

105.9

103

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.5

105.8

404

1263

HAB40

NOMESCO Finland

Wedge excision of mammary gland

18.1

105.4

L02BG04

ATC

letrozole; oral

9.7

105.2

124

132

L01AA02

ATC

chlorambucil; oral

218.2

103.1

106

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

4.3

102.7

278

683

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

102.6

GD1AD

NOMESCO Finland

Thorax CT examination

3.7

102.2

349

1013

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

25.8

102.1

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

101.5

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

8.0

101.4

139

179

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

4.2

101.3

284

716

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

23.3

100.9

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

984.2

98.5

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

3.3

97.7

401

1309

9591/3-C77.0

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of head, face and neck

+∞

97.3

20199

ICD-8 Finland

Hodgkin's disease

+∞

96.3

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

4.9

93.3

213

456

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

92.1

9691/3-C77.8

ICD-O-3

Follicular lymphoma, grade 2 of lymph nodes of multiple regions

+∞

92.1

L04.0

ICD-10 Finland

Acute lymphadenitis of face, head and neck

11.2

91.3

L01CB01

ATC

etoposide; systemic

+∞

90.0

9698/3-C77.9

ICD-O-3

Follicular lymphoma, grade 3 of lymph node, NOS

+∞

88.9

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.1

88.8

1215

7006

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

868.5

87.0

NK6AN

NOMESCO Finland

Total body bone isotope imaging

28.0

85.8

HAC20

NOMESCO Finland

Total mastectomy

133.2

85.3

ZX080

NOMESCO Finland

Image guided radiotherapy

+∞

84.7

2008X

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Other named variants

+∞

84.7

L01BC06

ATC

capecitabine; oral

+∞

84.7

A79

ICPC

Malignancy NOS

180.2

84.5

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

116.6

84.3

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.3

84.3

823

4145

A06AH03

ATC

naloxegol; oral

14.7

83.6

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.1

81.8

384

1353

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.4

80.5

308

959

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

5.0

79.5

174

359

JN3AD

NOMESCO Finland

Abdominal CT examination

2.5

78.5

555

2417

9650/3-C77.0

ICD-O-3

Hodgkin lymphoma, NOS, of lymph nodes of head, face and neck

+∞

78.4

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

+∞

77.4

JN4ED

NOMESCO Finland

Body CT examination with specail preparation

266.1

76.7

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

763.9

76.6

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

4.5

76.4

193

448

Y77

ICPC

Malignant neoplasm prostate

136.2

75.2

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

380.0

75.0

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

17.0

74.7

KCD02

NOMESCO Finland

Transurethral resection of bladder

14.9

74.2

I88.9

ICD-10 Finland

Nonspecific lymphadenitis, unspecified

13.2

73.4

WW409

NOMESCO Finland

Other aferesis

369.5

72.9

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

30.4

72.8

JAH00

NOMESCO Finland

Laparotomy

5.0

72.1

158

326

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.0

71.5

1105

6561

9663/3-C77.0

ICD-O-3

Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of head, face and neck

+∞

71.1

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

6.6

70.3

114

177

9673/3-C77.9

ICD-O-3

Mantle cell lymphoma of lymph node, NOS

+∞

70.0

ZXE00

NOMESCO Finland

One hour or less

1.9

69.8

1414

9166

WZC15, ,

NOMESCO Finland

32.5

69.7

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

29.1

68.8

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

6.3

68.6

116

188

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

15.8

68.4

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

124.1

68.1

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.7

67.8

404

1613

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

12.4

67.7

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

24.3

67.4

WX302

NOMESCO Finland

Thoracal epidural anesthesy

4.7

66.9

159

351

A41.9

ICD-10 Finland

Sepsis, unspecified

3.8

66.0

213

592

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

65.8

C96.9

ICD-10 Finland

Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified

+∞

65.8

ZXF99

NOMESCO Finland

Other r3eason to interrupt procedure

15.6

65.8

Z51.0

ICD-10 Finland

Radiotherapy session

333.0

65.7

C50.99

ICD-10 Finland

Breast, unspecified

333.0

65.7

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

333.0

65.7

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.6

65.0

220

631

7856A

ICD-9 Finland

Symptoms involving cardiovascular system, Enlargement of lymph nodes

27.8

64.8

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

4.7

64.1

152

335

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.5

63.9

465

2041

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

2.7

63.9

373

1472

C83.89

ICD-10 Finland

Other types of diffuse non-Hodgkin's lymphoma

+∞

63.7

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.9

63.6

1197

7531

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

12.9

63.2

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

6.0

62.9

112

191

9680/3-C77.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of head, face and neck

+∞

62.7

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

62.7

D69.5

ICD-10 Finland

Secondary thrombocytopenia

22.2

62.3

WX110

NOMESCO Finland

Infiltration anesthesia

1.8

62.1

2538

20072

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

618.4

62.0

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

4.1

61.8

178

456

9695/3-C77.9

ICD-O-3

Follicular lymphoma, grade 1 of lymph node, NOS

+∞

61.6

GEA00

NOMESCO Finland

Mediastinoscopy

18.4

61.2

A07AA02

ATC

nystatin; oral

3.0

60.6

282

984

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

7.1

60.6

133

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

21.7

60.4

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

130.2

60.0

WW200

NOMESCO Finland

Immunization

4.3

59.9

159

383

GEA20

NOMESCO Finland

Mediastinoscopy with excision of lesion

25.0

59.6

TGD00

NOMESCO Finland

Needle biopsy of lung

25.0

59.6

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

20.7

59.3

R4190

NOMESCO Finland

Nutritional therapy

4.2

58.4

160

395

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.0

57.9

832

4768

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

8.3

57.8

B02

ICPC

Lymph gland(s) enlarged/painful

8.6

57.6

FM1FN

NOMESCO Finland

Heart function isotope examination

+∞

57.4

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

5.4

57.0

114

217

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

5.1

56.9

122

247

2000B

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM DIFFUSUM]

+∞

56.4

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

56.4

C84.51

ICD-10 Finland

Other and unspecified T-cell lymphomas

+∞

56.4

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

6.4

56.0

151

TPJ00

NOMESCO Finland

Biopsy of superficial lymph node

90.1

56.0

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

556.3

55.7

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

556.3

55.7

J05AB01

ATC

aciclovir; systemic

1.9

55.6

841

4894

L02BB03

ATC

bicalutamide; oral

+∞

55.3

E83.50

ICD-10 Finland

Hypercalcemia

6.7

55.2

134

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

8.7

55.1

R06AE07

ATC

cetirizine; oral

1.7

55.0

1532

10715

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

10.9

54.9

C84.59

ICD-10 Finland

Other and unspecified T-cell lymphomas

+∞

54.3

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.5

53.9

361

1520

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

6.2

53.7

151

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

53.2

2015X

ICD-9 Finland

Hodgkin's disease, Nodular sclerosis[MORBUS HODGKIN, NODULAR SCLEROSIS, NUD]

+∞

53.2

WW402

NOMESCO Finland

Leucoferesis

+∞

53.2

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

6.2

53.2

149

JMA10

NOMESCO Finland

Transabdominal total splenectomy

19.7

52.9

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

52.2

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

75.1

52.1

JAL00

NOMESCO Finland

Biopsy of peritoneum

22.6

51.8

XX2RW, ,

NOMESCO Finland

8.8

51.8

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

6.5

51.5

131

JAH01

NOMESCO Finland

Laparoscopy

3.7

51.5

170

479

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.0

51.4

638

3458

9673/3-C77.8

ICD-O-3

Mantle cell lymphoma of lymph nodes of multiple regions

+∞

51.2

C83.0

ICD-10 Finland

Small cell B-cell lymphoma

+∞

51.2

1AA09, ,

NOMESCO Finland

+∞

51.2

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

73.8

51.1

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

6.9

50.4

115

D64.9

ICD-10 Finland

Anaemia, unspecified

2.2

50.4

501

2497

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

50.1

1234

8284

9699/3-C77.9

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of lymph node, NOS

+∞

50.1

XW4XT

NOMESCO Finland

Biopsy of other inner organ with radiological guidance guidance

81.3

50.0

ZZR00

NOMESCO Finland

Flap of skin

9.5

49.8

YNB10

NOMESCO Finland

Collection of stem cells for transplant

494.4

49.5

L57.0

ICD-10 Finland

Actinic keratosis

2.4

49.4

377

1683

H02AB09

ATC

hydrocortisone; systemic

4.4

49.3

126

295

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

49.2

1831

13703

9591/3-C77.4

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of inguinal region or leg

+∞

49.1

9652/3-C77.9

ICD-O-3

Hodgkin lymphoma, mixed cellularity, NOS, of lymph node, NOS

+∞

49.1

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

49.1

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.5

49.0

327

1373

Z31.6

ICD-10 Finland

General counselling and advice on procreation

9.3

48.4

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

5.4

48.0

179

9698/3-C77.8

ICD-O-3

Follicular lymphoma, grade 3 of lymph nodes of multiple regions

+∞

48.0

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

48.0

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

48.0

9591/3-C77.2

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of intra-abdominal lymph nodes

+∞

48.0

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

16.8

47.9

GD6AD

NOMESCO Finland

CT of chest and neck

16.2

46.9

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

10.1

46.9

C03CA01

ATC

furosemide; systemic

1.7

46.3

1280

8826

TQW99

NOMESCO Finland

Other minor procedure on skin

3.3

46.3

181

569

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

45.9

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

45.9

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

3.7

45.7

147

407

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.9

45.4

227

823

N02BE01

ATC

paracetamol; systemic, rectal

2.0

45.4

3229

28525

C81

ICD-10 Finland

Hodgkin lymphoma

453.2

45.3

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

5.3

45.0

175

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

6.8

45.0

104

C83.33

ICD-10 Finland

Primary medical lymphoma with large B cells

+∞

44.9

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

44.9

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

44.9

KA1FN

NOMESCO Finland

Isotope renography

9.8

44.8

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

44.4

1095

7306

C82.0

ICD-10 Finland

Follicular lymphoma grade I

+∞

43.8

C85.7

ICD-10 Finland

Other specified types of non-Hodgkin lymphoma

+∞

43.8

9659/3-C77.9

ICD-O-3

Hodgkin lymphoma, nodular lymphocyte predominant of lymph node, NOS

+∞

43.8

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

43.8

J01MA14

ATC

moxifloxacin; systemic

2.3

43.7

365

1691

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

5.0

43.2

189

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

42.8

390

Kela drug reimbursment

Ibrutinib

+∞

42.8

2009X

ICD-9 Finland

Lymphosarcoma and reticulosarcoma[LYMPHOMA MALIGNUM (NON-HODGKIN) NUD]

+∞

42.8

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

4.2

42.5

115

281

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

14.8

42.5

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

69.3

42.1

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

217.5

42.0

9659/3-C77.8

ICD-O-3

Hodgkin lymphoma, nodular lymphocyte predominant of lymph nodes of multiple regions

+∞

41.7

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

+∞

41.7

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

41.7

C83.2

ICD-10 Finland

Mixed small and large cell (diffuse) non-Hodgkin's lymphoma

+∞

41.7

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

41.7

C83.32

ICD-10 Finland

Centroblastic diffuse non-Hodgkin's lymphoma

+∞

41.7

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

41.6

1286

9066

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

412.1

41.2

YNB00

NOMESCO Finland

Excision of bone marrow for transplantation

212.4

40.9

PJ2HT

NOMESCO Finland

Biopsy of deep lymphnode with ultrasound guidance

+∞

40.7

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

40.7

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

+∞

40.7

AA1BD

NOMESCO Finland

Extensive CT of head and brain

4.6

40.6

219

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

40.6

460

2400

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

5.3

40.5

158

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

5.2

39.8

164

C83.35

ICD-10 Finland

T-cell-rich B-cell lymphoma

+∞

39.6

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

38.6

C82.7

ICD-10 Finland

Other types of follicular lymphoma

+∞

38.6

C83.01

ICD-10 Finland

Lymphoplasmacytic lymphoma

+∞

38.6

JAL01

NOMESCO Finland

Laparoscopic biopsy of peritoneum

56.9

38.3

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

37.6

9650/3-C77.9

ICD-O-3

Hodgkin lymphoma, NOS, of lymph node, NOS

+∞

37.6

1512

Kela drug reimbursment

Ibrutinib

+∞

37.6

C84.49

ICD-10 Finland

Peripheral T-cell lymphoma, unspecified cell type

+∞

37.6

9690/3-C77.8

ICD-O-3

Follicular lymphoma, NOS, of lymph nodes of multiple regions

+∞

37.6

9680/3-C77.2

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of intra-abdominal lymph nodes

+∞

37.6

C83.34

ICD-10 Finland

Anaplastic large cell lymphoma

+∞

37.6

ED1AA

NOMESCO Finland

Mandibular X-ray examination

9.3

37.4

127

Kela drug reimbursment

Transplant complication

5.2

37.3

151

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.3

37.2

143

445

B01AB04

ATC

dalteparin; parenteral

2.8

37.1

193

714

OAA41

NOMESCO Finland

Health check based on individual needs

371.1

37.1

JAH21

NOMESCO Finland

Staging laparoscopy

191.9

36.8

J94.8

ICD-10 Finland

Other specified pleural conditions

4.9

36.5

169

Z3231

NOMESCO Finland

Registered nurse

1.7

36.5

930

6204

J01DB01

ATC

cefalexin; oral

1.7

36.4

2899

25236

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

4.1

36.3

100

248

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

36.0

1438

10681

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

35.8

428

2270

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

35.5

L01BB05

ATC

fludarabine; systemic

+∞

35.5

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

35.5

D48.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other specified sites

8.2

35.5

ZXA05

NOMESCO Finland

Left side

1.7

35.3

853

5605

L02BG06

ATC

exemestane; oral

350.5

35.0

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

78.9

34.9

X76

ICPC

Malignant neoplasm breast female

124.6

34.7

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

124.6

34.7

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.6

34.4

212

854

C84.5

ICD-10 Finland

Other mature T/NK-cell lymphomas

+∞

34.4

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

34.4

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

7.4

33.9

C50

ICD-10 Finland

Malignant neoplasm of breast

176.6

33.8

R4110

NOMESCO Finland

Physiotherapy

1.6

33.8

929

6299

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

33.4

2019X

ICD-9 Finland

Hodgkin's disease, unspecified

+∞

33.4

C83

ICD-10 Finland

Non-follicular lymphoma

+∞

33.4

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

33.4

9702/3-C77.9

ICD-O-3

Mature T-cell lymphoma, NOS, of lymph node, NOS

+∞

33.4

C82

ICD-10 Finland

Follicular lymphoma

+∞

33.4

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

56.3

33.2

B03XA02

ATC

darbepoetin alfa; parenteral

4.2

32.8

214

L01XX52

ATC

venetoclax; oral

+∞

32.3

9695/3-C77.8

ICD-O-3

Follicular lymphoma, grade 1 of lymph nodes of multiple regions

+∞

32.3

399

Kela drug reimbursment

Venetoclax

+∞

32.3

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

32.3

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

32.3

WX002

NOMESCO Finland

Sedation and analgesia

1.7

32.3

686

4341

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

40.5

32.1

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.9

32.1

153

540

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

6.0

32.0

C90.0

ICD-10 Finland

Multiple myeloma

319.8

31.9

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

166.4

31.7

PJ4AT

NOMESCO Finland

Labeling lymphnode with ultrasound guidance

166.4

31.7

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

6.9

31.4

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

31.3

TAB00

NOMESCO Finland

Lumbar puncture

2.6

31.3

183

719

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

315.5

30.9

Z2221

NOMESCO Finland

Medical doctor

1.6

30.8

874

5949

ZXA00

NOMESCO Finland

Right side

1.6

30.8

919

6332

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

4.1

30.8

207

C91.9

ICD-10 Finland

Lymphoid leukaemia, unspecified

+∞

30.2

20298

ICD-8 Finland

Other neoplasms of lymphoid tissue, Lymphomata alia

+∞

30.2

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

30.2

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

30.2

9705/3-C77.9

ICD-O-3

Angioimmunoblastic T-cell lymphoma of lymph node, NOS

+∞

30.2

2000A

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM FOLLICULARE]

+∞

30.2

C84.4

ICD-10 Finland

Peripheral T-cell lymphoma, not elsewhere classified

+∞

30.2

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

30.2

ZXC96

NOMESCO Finland

Robot assisted procedure

7.7

30.2

A41.8

ICD-10 Finland

Other specified sepsis

3.6

30.0

279

TPH07

NOMESCO Finland

Cathetrisation of artery

1.9

29.6

388

2120

N02AX02

ATC

tramadol; systemic, rectal

1.5

29.5

1457

11194

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

+∞

29.2

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

29.2

9691/3-C77.0

ICD-O-3

Follicular lymphoma, grade 2 of lymph nodes of head, face and neck

+∞

29.2

L01EL01

ATC

ibrutinib; oral

+∞

29.2

SPAT1153

SPAT

Removal of sutures

1.5

29.2

1055

7581

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

4.5

28.9

157

128

Kela drug reimbursment

Cancers of female genital organs

294.2

28.8

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

28.7

942

6621

J01MA02

ATC

ciprofloxacin; systemic

1.5

28.7

1342

10180

EP1DG

NOMESCO Finland

Very extensive examination of soft tissue of neck with high intesity magnet

7.6

28.4

JFB00

NOMESCO Finland

Partial resection of small intestine

4.6

28.2

148

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

28.2

9591/3-C77.8

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of multiple regions

+∞

28.2

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

+∞

28.2

C83.71

ICD-10 Finland

Burkitt's tumour

+∞

28.2

1518, ,

Kela drug reimbursment

+∞

28.2

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.2

28.1

244

1145

PJ2CT

NOMESCO Finland

Biopsy of lymphnode with CT guidance

283.6

27.8

D37.00

ICD-10 Finland

Aryepiglottic fold marginal zone

9.8

27.7

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

5.1

27.5

116

XX3AT

NOMESCO Finland

Other labeling with ultrasound guidance

35.3

27.4

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

4.9

27.4

124

S18

ICPC

Laceration/cut

1.5

27.3

1609

12742

HAB99

NOMESCO Finland

Other partial excision of mammary gland

6.8

27.2

Z2446

NOMESCO Finland

Social worker

2.3

27.1

218

990

9823/3-C77.8

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph nodes of multiple regions

+∞

27.1

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

27.1

9690/3-C77.4

ICD-O-3

Follicular lymphoma, NOS, of lymph nodes of inguinal region or leg

+∞

27.1

9652/3-C77.0

ICD-O-3

Hodgkin lymphoma, mixed cellularity, NOS, of lymph nodes of head, face and neck

+∞

27.1

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

27.1

XX1AD

NOMESCO Finland

Other CT-examination

62.5

27.0

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

75.7

26.8

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

97.5

26.7

N05CF01

ATC

zopiclone; oral

1.5

26.6

1092

8035

S04

ICPC

Lump/swelling localized

1.9

26.5

390

2208

B02.9

ICD-10 Finland

Zoster without complication

2.1

26.5

281

1423

UJF32

NOMESCO Finland

Coloscopy

1.6

26.4

877

6160

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

6.0

26.4

J02AC03

ATC

voriconazole; systemic

29.4

26.3

EP1AE, ,

SPAT

3.6

26.2

251

A07AA09

ATC

vancomycin; oral

4.1

26.1

179

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

+∞

26.1

9652/3-C77.8

ICD-O-3

Hodgkin lymphoma, mixed cellularity, NOS, of lymph nodes of multiple regions

+∞

26.1

3AA13, ,

NOMESCO Finland

+∞

26.1

9670/3-C77.9

ICD-O-3

Malignant lymphoma, small B lymphocytic, NOS, of lymph node, NOS

+∞

26.1

9680/3-C77.4

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of inguinal region or leg

+∞

26.1

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

3.5

25.9

253

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

3.4

25.7

279

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

94.1

25.7

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

24.2

25.7

D04.4

ICD-10 Finland

Carcinoma in situ: Skin of scalp and neck

7.8

25.5

ZXC15

NOMESCO Finland

Use of photodynamic technique

5.8

25.4

D11.0

ICD-10 Finland

Benign neoplasm: Parotid gland

3.7

25.3

224

A06AD11

ATC

lactulose; oral

1.7

25.2

547

3464

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

25.0

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

25.0

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

25.0

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

25.0

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

25.0

9650/3-C77.1

ICD-O-3

Hodgkin lymphoma, NOS, of intrathoracic lymph nodes

+∞

25.0

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

25.0

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

58.4

25.0

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.1

24.8

107

357

5702

FHL

Local lymph node removal (eg armpit, groin)

70.4

24.8

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

251.9

24.7

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

251.9

24.7

YX9AW, ,

NOMESCO Finland

251.9

24.7

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

251.9

24.7

YA1CD

NOMESCO Finland

Very extensive CT examination of head and neck for dose design of radiotherapy

130.9

24.6

D48.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Retroperitoneum

32.3

24.6

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.2

24.3

200

917

WPA13

NOMESCO Finland

Palliative consultation

9.7

24.1

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

24.0

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

24.0

L02BB04

ATC

enzalutamide; oral

+∞

24.0

9699/3-C77.8

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of lymph nodes of multiple regions

+∞

24.0

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

24.0

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

+∞

24.0

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

24.0

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

+∞

24.0

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

5.0

23.9

103

L01AA01

ATC

cyclophosphamide; systemic

9.4

23.5

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

5.9

23.5

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

22.9

C83.8

ICD-10 Finland

Other non-follicular lymphoma

+∞

22.9

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

22.9

9591/3-C77.3

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of axilla or arm

+∞

22.9

C88.9

ICD-10 Finland

Malignant immunoproliferative disease, unspecified

+∞

22.9

9690/3-C77.0

ICD-O-3

Follicular lymphoma, NOS, of lymph nodes of head, face and neck

+∞

22.9

9663/3-C77.1

ICD-O-3

Hodgkin lymphoma, nodular sclerosis, NOS, of intrathoracic lymph nodes

+∞

22.9

A04AA03

ATC

tropisetron; systemic

65.4

22.8

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

65.4

22.8

JAH20

NOMESCO Finland

Staging laparotomy

65.4

22.8

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.5

22.7

143

582

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

84.0

22.7

121

Kela drug reimbursment

Severe hypofunction of sexual glands

3.6

22.7

217

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

231.4

22.6

TJF80

NOMESCO Finland

Ostomy education

8.0

22.1

9659/3-C77.3

ICD-O-3

Hodgkin lymphoma, nodular lymphocyte predominant of lymph nodes of axilla or arm

+∞

21.9

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

21.9

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

21.9

L01XE27

ATC

[U] ibrutinib

+∞

21.9

C80.0

ICD-10 Finland

Malignant neoplasm, primary site unknown, so stated

+∞

21.9

9680/3-C77.3

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of axilla or arm

+∞

21.9

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

21.9

2016A

ICD-9 Finland

Hodgkin's disease, Mixed cellularity

+∞

21.9

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

21.9

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

21.9

C88.0

ICD-10 Finland

Waldenström macroglobulinaemia

+∞

21.9

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

21.9

WF099

NOMESCO Finland

Other radiotherapy

29.2

21.8

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.4

21.7

233

V03AF03

ATC

calcium folinate; systemic

221.3

21.6

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

115.7

21.6

JN4DD

NOMESCO Finland

Scout CT scan of torso

115.7

21.6

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

4.0

21.5

155

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.7

21.4

112

416

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

5.9

21.3

ZX100

NOMESCO Finland

Oral

4.1

21.3

143

ZXC50

NOMESCO Finland

Cryotherapy

3.1

21.2

303

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

6.0

21.2

L02AE03

ATC

goserelin; implant

9.0

21.2

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

3.7

21.2

184

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

5.8

21.0

R50.8

ICD-10 Finland

Other specified fever

6.5

20.9

9591/3-C77.1

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of intrathoracic lymph nodes

+∞

20.8

6103

FHL

Staging laparotomy (to study the reticuloendothelial system)

+∞

20.8

9651/3-C77.9

ICD-O-3

Hodgkin lymphoma, lymphocyte-rich of lymph node, NOS

+∞

20.8

C81.3

ICD-10 Finland

Lymphocyte depleted classical Hodgkin lymphoma

+∞

20.8

ZXD05

NOMESCO Finland

Urgent procedure

1.5

20.7

967

7232

J01CA04

ATC

amoxicillin; systemic

1.5

20.7

2757

24727

WE300

NOMESCO Finland

Profylactive therapy of malignancy with biomoidiers

110.7

20.6

XKD00

NOMESCO Finland

Uroflowmetry

1.6

20.6

519

3402

JFB30

NOMESCO Finland

Right hemicolectomy

6.3

20.5

UKC02

NOMESCO Finland

Cystoscopy

1.6

20.5

534

3528

S77

ICPC

Malignant neoplasm of skin

25.6

20.4

ZX121

NOMESCO Finland

Central venous catheter

25.6

20.4

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.1

20.4

204

1011

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.4

20.3

137

576

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

20.2

20.3

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

20.2

20.3

ELB30

NOMESCO Finland

Excision of submandibular gland

6.2

20.2

L02BG03

ATC

anastrozole; oral

48.3

20.1

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

19.9

328

1917

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

+∞

19.8

2014A

ICD-9 Finland

Hodgkin's disease, Lymphocytic-histiocytic predominance[MORBUS HODGKIN,""""LYMPHOCYTIC PREDOMINANCE"""",""""NODULAR""""]

+∞

19.8

C80.9

ICD-10 Finland

Malignant neoplasm, primary site unspecified

+∞

19.8

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

19.8

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

19.8

9702/3-C77.8

ICD-O-3

Mature T-cell lymphoma, NOS, of lymph nodes of multiple regions

+∞

19.8

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

19.8

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

3.6

19.7

179

Z52.89

ICD-10 Finland

Donor of other organ or tissue

73.9

19.7

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

73.9

19.7

KA3EB

NOMESCO Finland

Antegrade pyelography

8.2

19.6

XW4CT

NOMESCO Finland

Biopsy of other inner organ with CT guidance

201.0

19.6

120

Kela drug reimbursment

Hypogammaglobulinaemia

24.7

19.5

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

4.0

19.5

135

TNE20

NOMESCO Finland

Bone marrow aspiration, pelvis

21.7

19.5

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

21.7

19.5

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

19.4

551

3709

TGE00

NOMESCO Finland

Needle biopsy of mediastinum

14.7

19.4

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.7

19.3

102

381

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.5

19.1

624

4331

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.1

18.9

125

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

14.9

18.9

1CX01, ,

NOMESCO Finland

34.5

18.9

JN5KR

NOMESCO Finland

Very extensive PET-CT of upper body metabolism (eyebrows to thighs)

34.5

18.9

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

3.0

18.8

292

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

18.8

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

18.8

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

18.8

C84.43

ICD-10 Finland

Peripheral T-cell lymphoma, large cell type

+∞

18.8

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

18.8

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

18.8

PJD43

NOMESCO Finland

Excision of aortic lymph nodes

+∞

18.8

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

18.8

L02BX02

ATC

degarelix; parenteral

+∞

18.8

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

18.8

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

18.8

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

70.2

18.7

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

7.7

18.7

EL4AT

NOMESCO Finland

Salivary gland cytology with ultrasound guidance

7.0

18.6

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

100.6

18.6

C20

ICD-10 Finland

Malignant neoplasm of rectum

190.9

18.5

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

14.2

18.5

L04AD01

ATC

ciclosporin; systemic

3.3

18.3

208

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

18.2

444

2882

WVA20

NOMESCO Finland

Medicine administration

2.7

18.0

372

N05BA06

ATC

lorazepam; systemic, sublingual

2.1

18.0

183

913

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

17.9

1125

8832

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

6.7

17.8

A02BC01

ATC

omeprazole; systemic

1.4

17.8

899

6791

372

Kela drug reimbursment

Idelalisib

+∞

17.7

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

17.7

C83.51

ICD-10 Finland

B-lymphoblastic lymphoma or leukemia

+∞

17.7

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

+∞

17.7

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

17.7

2015A

ICD-9 Finland

Hodgkin's disease, Nodular sclerosis[MORBUS HODGKIN, NODULAR SCLEROSIS, CELLULAR PHASE]

+∞

17.7

3054, ,

Kela drug reimbursment

+∞

17.7

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

17.7

1523, ,

Kela drug reimbursment

+∞

17.7

L01CA04

ATC

vinorelbine; systemic

+∞

17.7

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

66.9

17.7

9101

FHL

Bone biopsy

20.1

17.7

C44.52

ICD-10 Finland

Spinocellular carcinoma of the skin on the torso

36.9

17.6

B74

ICPC

Malignant neoplasm blood other

95.5

17.6

B73

ICPC

Leukaemia

180.8

17.5

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

180.8

17.5

PJD99

NOMESCO Finland

Excision of other lymph nodes

180.8

17.5

L02AE04

ATC

triptorelin; parenteral

180.8

17.5

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

4.5

17.5

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

6.8

17.4

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

3.5

17.4

175

ZX114

NOMESCO Finland

Intramuscular

4.0

17.4

120

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

21.0

17.3

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

3.3

17.1

192

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

16.9

752

5541

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

3.4

16.8

179

L02BX03

ATC

abiraterone; oral

+∞

16.7

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

16.7

CBB50

NOMESCO Finland

Excision of lesion of eyelid and reconstruction using graft or flap

+∞

16.7

8070/3-C80.9

ICD-O-3

Squamous cell carcinoma, NOS, of unknown primary site

+∞

16.7

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

16.7

9651/3-C77.0

ICD-O-3

Hodgkin lymphoma, lymphocyte-rich of lymph nodes of head, face and neck

+∞

16.7

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

16.7

C83.40

ICD-10 Finland

Immunoblast large cell lymphoma

+∞

16.7

N03AX16

ATC

[U] pregabalin

1.5

16.6

714

5229

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

4.5

16.6

I42.7

ICD-10 Finland

Cardiomyopathy due to drugs and other external agents

90.5

16.6

SPAT1088

SPAT

Blood transfusion

7.3

16.5

C76.2

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Abdomen

170.7

16.5

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

4.4

16.3

WX892

NOMESCO Finland

Monitored bed care

1.8

16.3

259

1498

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.2

16.1

141

664

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

3.7

16.1

136

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

47.7

16.0

OAB77

NOMESCO Finland

Discussion on exercise habits and instruction concerning use of sports and fitness services

47.7

16.0

L01XX05

ATC

hydroxycarbamide; oral

21.0

16.0

EP3AT

NOMESCO Finland

Neck soft tissue biopsy with ultrasound guidance

60.3

15.8

9590/3-C77.9

ICD-O-3

Malignant lymphoma, NOS, of lymph node, NOS

+∞

15.6

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

15.6

9659/3-C77.0

ICD-O-3

Hodgkin lymphoma, nodular lymphocyte predominant of lymph nodes of head, face and neck

+∞

15.6

9690/3-C77.2

ICD-O-3

Follicular lymphoma, NOS, of intra-abdominal lymph nodes

+∞

15.6

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

15.6

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

2.9

15.6

251

Z51.3

ICD-10 Finland

Blood transfusion (without reported diagnosis)

160.7

15.5

N02AA01

ATC

morphine; systemic, rectal

3.2

15.4

189

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.4

15.4

101

420

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

14.8

15.3

A05AA02

ATC

ursodeoxycholic acid; oral

3.2

15.2

186

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

4.1

15.1

101

WPB10

NOMESCO Finland

Making a convalescent care decision

17.8

15.1

R11

ICD-10 Finland

Nausea and vomiting

1.7

15.1

270

1614

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

20.1

15.1

WX704

NOMESCO Finland

Intubation

1.8

15.0

236

1360

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.9

14.9

183

976

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

56.9

14.8

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

56.9

14.8

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

14.8

499

3477

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

14.6

212

1193

9680/3-C42.1

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of bone marrow

+∞

14.6

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

14.6

8000/3-C80.9

ICD-O-3

Neoplasm, malignant of unknown primary site

+∞

14.6

C83.59

ICD-10 Finland

Lymphoblastic lymphoma of indeterminate type

+∞

14.6

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

14.6

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

14.6

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

14.6

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

14.6

C84.41

ICD-10 Finland

Peripheral T-cell lymphoma, medium-sized cell type

+∞

14.6

C84.0

ICD-10 Finland

Mycosis fungoides

+∞

14.6

EP2AT

NOMESCO Finland

Neck soft tissue cytology with ultrasound guidance

11.9

14.5

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.3

14.5

113

508

L04AA01

ATC

[U] ciclosporin

3.4

14.5

156

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

3.9

14.5

109

M05BX04

ATC

denosumab; parenteral

2.0

14.5

167

872

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

150.6

14.5

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

150.6

14.5

Z92.6

ICD-10 Finland

Personal history of chemotherapy for neoplastic disease

150.6

14.5

H03AA01

ATC

levothyroxine sodium; systemic

1.4

14.4

694

5174

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

14.4

1393

11590

R86.0

ICD-10 Finland

Abnormal findings in specimens from male genital organs, abnormal level of enzymes

3.3

14.1

159

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

14.1

1169

9508

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.6

14.0

306

J02AC01

ATC

fluconazole; systemic

1.3

13.9

1053

8444

R59

ICD-10 Finland

Enlarged lymph nodes

30.1

13.9

E0000UV, ,

ATC

1.3

13.7

1283

10603

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

2.5

13.7

357

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

4.1

13.7

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.1

13.6

126

607

C77.5

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes

+∞

13.5

C85.0

ICD-10 Finland

Lymphosarcoma

+∞

13.5

9650/3-C77.8

ICD-O-3

Hodgkin lymphoma, NOS, of lymph nodes of multiple regions

+∞

13.5

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

+∞

13.5

L03AB05

ATC

interferon alfa-2b; parenteral

+∞

13.5

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

13.5

9691/3-C77.4

ICD-O-3

Follicular lymphoma, grade 2 of lymph nodes of inguinal region or leg

+∞

13.5

9695/3-C77.0

ICD-O-3

Follicular lymphoma, grade 1 of lymph nodes of head, face and neck

+∞

13.5

9670/3-C77.0

ICD-O-3

Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of head, face and neck

+∞

13.5

C91.7

ICD-10 Finland

Other lymphoid leukaemia

+∞

13.5

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

13.5

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

13.5

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

13.5

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

3.4

13.5

143

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.5

13.5

354

ZZA50

NOMESCO Finland

Full thickness skin graft

16.2

13.4

R93.8

ICD-10 Finland

Abnormal findings on diagnostic imaging of other specified body structures

5.2

13.4

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

3.3

13.4

149

JMA11

NOMESCO Finland

Laparoscopic total splenectomy

25.8

13.4

R16.1

ICD-10 Finland

Splenomegaly, not elsewhere classified

18.3

13.4

104

Kela drug reimbursment

Thyroid insufficiency

1.8

13.3

210

1212

B03XA01

ATC

erythropoietin; parenteral

4.5

13.3

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.7

13.3

257

C44.50

ICD-10 Finland

Malignant tumor of the skin on the torso without histology

40.2

13.1

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

4.3

13.1

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

5.9

13.0

Z51.88

ICD-10 Finland

Other specified medical care

2.6

13.0

300

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.0

12.9

142

729

R18

ICD-10 Finland

Ascites

3.0

12.9

194

L04AA06

ATC

mycophenolic acid; systemic

2.8

12.9

238

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.3

12.9

437

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

50.2

12.8

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

50.2

12.8

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

2.2

12.8

108

502

I50.1

ICD-10 Finland

Left ventricular failure

1.8

12.8

212

1241

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.9

12.8

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

12.7

144

748

WX725

NOMESCO Finland

Noninvasive ventilation

1.9

12.6

168

921

I89.9

ICD-10 Finland

Noninfective disorder of lymphatic vessels and lymph nodes, unspecified

15.5

12.6

C44.22

ICD-10 Finland

Spinocellular carcinoma of the skin of the outer ear and the outer ear canal

70.1

12.6

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

70.1

12.6

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.4

12.5

655

4943

9989/3-C42.1

ICD-O-3

Myelodysplastic syndrome, NOS, of bone marrow

+∞

12.5

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

12.5

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

+∞

12.5

AAG00

NOMESCO Finland

Stereotactic intracranial biopsy

+∞

12.5

C83.5

ICD-10 Finland

Lymphoblastic (diffuse) lymphoma

+∞

12.5

WW306

NOMESCO Finland

Transfer of stem cells from foreign registered donator

+∞

12.5

9695/3-C77.4

ICD-O-3

Follicular lymphoma, grade 1 of lymph nodes of inguinal region or leg

+∞

12.5

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

12.5

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

12.5

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

+∞

12.5

C83.70

ICD-10 Finland

Non-Hodgkin's lymphoma of the Burkitt type

+∞

12.5

20013

ICD-8 Finland

Lymphosarcoma and reticulum-cell sarcoma, Lymphosarcoma loco alio (lymphonodis intrathoracalibus et intra-abdominalibus inclusis)

+∞

12.5

C83.6

ICD-10 Finland

Undifferentiated (diffuse) non-Hodgkin's lymphoma

+∞

12.5

GD6BD

NOMESCO Finland

Extensive CT of chest and neck

24.4

12.5

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

130.4

12.4

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

130.4

12.4

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.6

12.4

266

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.8

12.4

191

1095

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

4.8

12.4

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

12.4

254

1577

Z10.8

ICD-10 Finland

Routine general health check-up of other defined subpopulations

2.3

12.2

396

B04

ICPC

Blood symptom/complaint

5.1

12.2

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

4.0

12.2

N06DX01

ATC

memantine; oral

0.5

12.2

108

2130

D46.9

ICD-10 Finland

Myelodysplastic syndrome, unspecified

12.4

12.1

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

11.1

12.0

D11.70

ICD-10 Finland

Gland sublingual

10.1

12.0

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

9.3

12.0

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

3.5

11.9

115

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

46.8

11.9

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

2.7

11.7

233

EMA10

NOMESCO Finland

Biopsy of tonsil

9.6

11.7

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.3

11.7

366

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

3.7

11.6

EB1BA

NOMESCO Finland

Extensive intraoral X-ray examination

5.5

11.6

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

2.1

11.6

112

549

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

65.2

11.6

TK800

NOMESCO Finland

Hemodialysis

2.4

11.6

330

C779, 9715, 3

ICD-O-3

+∞

11.5

9705/3-C77.8

ICD-O-3

Angioimmunoblastic T-cell lymphoma of lymph nodes of multiple regions

+∞

11.5

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

+∞

11.5

9690/3-C77.3

ICD-O-3

Follicular lymphoma, NOS, of lymph nodes of axilla or arm

+∞

11.5

PJ002

NOMESCO Finland

Radical radiotherapy of neck, clavicle and axilla

+∞

11.5

9687/3-C77.9

ICD-O-3

Burkitt lymphoma, NOS, of lymph node, NOS

+∞

11.5

WW302

NOMESCO Finland

Allogenic transfer of stem cells from relative

+∞

11.5

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

11.5

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

11.5

9688/3-C77.9

ICD-O-3

T-cell/histiocyte rich large B-cell lymphoma of lymph node, NOS

+∞

11.5

9698/3-C77.0

ICD-O-3

Follicular lymphoma, grade 3 of lymph nodes of head, face and neck

+∞

11.5

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

11.5

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

11.5

C92.1

ICD-10 Finland

Chronic myeloid leukaemia [CML], BCR/ABL-positive

+∞

11.5

L01XX47

ATC

[U] idelalisib

+∞

11.5

D45

ICD-10 Finland

Polycythaemia vera

13.6

11.4

E89.4

ICD-10 Finland

Postprocedural ovarian failure

120.4

11.4

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

120.4

11.4

WX702

NOMESCO Finland

Supraglottic ventilation device

1.8

11.3

155

857

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

15.1

11.3

TQW20

NOMESCO Finland

Tatoe

35.1

11.3

R84

ICPC

Malignant neoplasm bronchus/lung

35.1

11.3

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

5.1

11.3

J12.8

ICD-10 Finland

Other viral pneumonia

3.5

11.2

110

WVA30

NOMESCO Finland

Intramuscular and subcutaneous injection

8.9

11.2

QX4AT

NOMESCO Finland

Ultrsound guided needle biopsy of skin

8.9

11.2

D46.7

ICD-10 Finland

Other myelodysplastic syndromes

12.7

11.1

5701

FHL

Local exploration of lymph nodes (includes biopsy)

43.4

10.9

J01FF01

ATC

clindamycin; systemic

1.3

10.8

817

6511

6753

FHL

Transabdominal splenectomy

15.5

10.8

C10AA07

ATC

rosuvastatin; oral

0.8

10.8

783

9715

6BA02, ,

NOMESCO Finland

9.6

10.7

D59.1

ICD-10 Finland

Other autoimmune haemolytic anaemias

4.9

10.7

B00.2

ICD-10 Finland

Herpesviral gingivostomatitis and pharyngotonsillitis

5.6

10.7

TGA30

NOMESCO Finland

Thoracocentesis

4.1

10.7

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

10.6

831

6653

D77

ICPC

Malignant digestive neopl other/NOS

60.2

10.6

R06.0

ICD-10 Finland

Dyspnoea

1.3

10.6

904

7327

A03

ICPC

Fever

1.4

10.6

456

3321

R93.5

ICD-10 Finland

Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum

3.1

10.6

135

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.0

10.5

111

564

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

10.5

175

1028

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

10.4

178

1052

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

110.3

10.4

D47.3

ICD-10 Finland

Essential (haemorrhagic) thrombocythaemia

110.3

10.4

Z08.2

ICD-10 Finland

Follow-up examination after chemotherapy for malignant neoplasm

+∞

10.4

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

10.4

YN1AD

NOMESCO Finland

CT examination of extremities for dose design of radiotherapy

+∞

10.4

C07.70

ICD-10 Finland

Malignant tumor of the superficial part of the parotid gland

+∞

10.4

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

10.4

KCC10

NOMESCO Finland

Cystoprostatectomy

+∞

10.4

8000/3-C25.9

ICD-O-3

Neoplasm, malignant of pancreas, NOS

+∞

10.4

9691/3-C77.2

ICD-O-3

Follicular lymphoma, grade 2 of intra-abdominal lymph nodes

+∞

10.4

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

+∞

10.4

1XC12, ,

NOMESCO Finland

+∞

10.4

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

+∞

10.4

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

+∞

10.4

NK6AQ

NOMESCO Finland

Whole body bone SPET with low dose CT

+∞

10.4

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

10.4

9861/3-C42.1

ICD-O-3

Acute myeloid leukemia, NOS, of bone marrow

+∞

10.4

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

10.4

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

10.4

JN4DG

NOMESCO Finland

Body very extensive MRI with high intensity magnet

+∞

10.4

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

10.4

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

+∞

10.4

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

10.4

C43.62

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type

+∞

10.4

9670/3-C77.8

ICD-O-3

Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of multiple regions

+∞

10.4

EP1BG

NOMESCO Finland

MRI examination of soft tissue of neck with high intesity magnet

7.7

10.4

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.4

10.4

428

3093

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

10.3

316

4704

FHL

Neck tumor removal

12.1

10.3

L03AA04, ,

ATC

32.6

10.3

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

2.6

10.3

226

J94.9

ICD-10 Finland

Pleural condition, unspecified

4.9

10.3

ELB00

NOMESCO Finland

Excision or exploration of lesion of salivary gland

13.1

10.1

QAB10

NOMESCO Finland

Major dressing of wound of skin of head or neck

5.3

10.1

J01MA01

ATC

ofloxacin; systemic

1.6

10.1

253

1649

I50.9

ICD-10 Finland

Heart failure, unspecified

1.4

10.1

532

4009

ENA10

NOMESCO Finland

Biopsy of pharynx

7.9

10.1

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

7.9

10.1

D04.2

ICD-10 Finland

Carcinoma in situ: Skin of ear and external auricular canal

11.3

10.0

JDB10

NOMESCO Finland

Percutaneous gastrostomy

3.5

10.0

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

10.0

618

4777

DAB10

NOMESCO Finland

Partial excision of auricle

40.2

10.0

C44.3

ICD-10 Finland

Malignant neoplasm: Skin of other and unspecified parts of face

40.2

10.0

KH1AA

NOMESCO Finland

Urinary tract X-ray examination without contrast

2.8

9.9

167

DHB00

NOMESCO Finland

Excision of lesion of external nose

7.6

9.9

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.2

9.9

348

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

9.9

595

4580

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

16.7

9.9

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

2.8

9.8

168

Z31.8

ICD-10 Finland

Other procreative management

26.1

9.8

GDB21

NOMESCO Finland

Thoracoscopic segmental resection of lung

26.1

9.8

B59

ICD-10 Finland

Pneumocystosis

26.1

9.8

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

20.1

9.8

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

9.5

9.7

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.8

9.7

147

840

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.7

9.7

192

XQ848

NOMESCO Finland

Dermatological photography

2.2

9.7

377

KAD00

NOMESCO Finland

Partial nephrectomy

13.4

9.7

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.4

9.6

504

3795

QCA25

NOMESCO Finland

Destruction of lesion of skin of upper limb

4.8

9.5

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

4.6

9.5

EBA10

NOMESCO Finland

Operative extraction of tooth

1.5

9.5

338

2374

HAE00

NOMESCO Finland

Reconstruction of breast using prosthesis

100.3

9.4

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

100.3

9.4

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

100.3

9.4

D76.1

ICD-10 Finland

Haemophagocytic lymphohistiocytosis

100.3

9.4

Z3226

NOMESCO Finland

Physiotherapist

1.4

9.4

504

3807

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

17.6

9.4

L01EL02

ATC

acalabrutinib; oral

+∞

9.4

394

Kela drug reimbursment

Palbociclib

+∞

9.4

C32.0

ICD-10 Finland

Malignant neoplasm: Glottis

+∞

9.4

C16.00

ICD-10 Finland

Cardia

+∞

9.4

C90.2

ICD-10 Finland

Extramedullary plasmacytoma

+∞

9.4

C83.52

ICD-10 Finland

T-lymphoblastic lymphoma or leukemia

+∞

9.4

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

+∞

9.4

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

9.4

C77.4

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes

+∞

9.4

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

+∞

9.4

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

9.4

C44.02

ICD-10 Finland

Spinocellular carcinoma of the lip skin

+∞

9.4

C80

ICD-10 Finland

Malignant neoplasm, without specification of site

+∞

9.4

189

Kela drug reimbursment

Imatinib

+∞

9.4

C83.7

ICD-10 Finland

Burkitt lymphoma

+∞

9.4

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

9.4

9823/3-C77.0

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph nodes of head, face and neck

+∞

9.4

WX1DG

NOMESCO Finland

Very extensive total body MRI with high intensity magnet

+∞

9.4

C85

ICD-10 Finland

Other and unspecified types of non-Hodgkin lymphoma

+∞

9.4

1501

Kela drug reimbursment

Palbociclib

+∞

9.4

XX1XN

NOMESCO Finland

Other isotope examination

+∞

9.4

8743/3-C44.9

ICD-O-3

Low cumulative sun damage melanoma of skin, NOS

+∞

9.4

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

+∞

9.4

D86.1

ICD-10 Finland

Sarcoidosis of lymph nodes

4.2

9.4

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

9.3

308

2131

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.5

9.3

296

2033

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

9.3

348

2468

I34.2

ICD-10 Finland

Nonrheumatic mitral (valve) stenosis

4.5

9.3

QBA10

NOMESCO Finland

Incision of skin of trunk

3.3

9.3

104

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.8

9.2

141

809

B99

ICPC

Blood/lymph/spleen disease other

7.3

9.2

A02BC05

ATC

esomeprazole; systemic

1.3

9.2

1245

10655

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.6

9.1

206

1310

KEB00

NOMESCO Finland

Biopsy of prostate

4.3

9.1

G53.0

ICD-10 Finland

Postzoster neuralgia

3.5

9.1

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

9.0

240

1586

R05

ICD-10 Finland

Cough

1.3

9.0

675

5360

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.5

9.0

1639

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

2.8

9.0

160

G04BE03

ATC

sildenafil; oral

3.8

8.9

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.7

8.9

143

831

C44.91

ICD-10 Finland

Unspecified localization of basocellular carcinoma of the skin

18.6

8.9

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

18.6

8.9

B00.19

ICD-10 Finland

Other vesicular dermatitis caused by the herper simplex virus

3.7

8.9

ELB40

NOMESCO Finland

Partial parotidectomy

3.0

8.9

128

6101

FHL

Exploratory laparotomy, includes possible biopases

4.9

8.8

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

7.2

8.7

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.8

8.7

126

711

N06DA02

ATC

donepezil; oral

0.5

8.7

1648

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

50.1

8.7

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

50.1

8.7

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

50.1

8.7

B29

ICPC

Lymph/immune mech sympt/complt other

7.6

8.6

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.6

8.6

187

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

2.7

8.5

170

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

2.8

8.5

142

9109

FHL

Other measure in this category

9.0

8.5

D06BB10

ATC

imiquimod; topical

1.8

8.5

135

783

P20

ICPC

Memory disturbance

0.7

8.5

296

4143

A21

ICPC

Risk factor for malignancy

27.6

8.5

J94.0

ICD-10 Finland

Chylous effusion

27.6

8.5

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

3.3

8.5

GDB10

NOMESCO Finland

Wedge resection of lung

20.1

8.5

T80.8

ICD-10 Finland

Other complications following infusion, transfusion and therapeutic injection

20.1

8.5

QX3HE, ,

SPAT

2.4

8.4

249

L04.9

ICD-10 Finland

Acute lymphadenitis, unspecified

7.3

8.4

JL2AT

NOMESCO Finland

Cytology of pancreas with ultrasound guidance

90.3

8.4

PJD51

NOMESCO Finland

Block dissection of cervical lymph nodes

90.3

8.4

JN6CD

NOMESCO Finland

Very extensive CT of torso and neck

90.3

8.4

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

90.3

8.4

WW200, ,

SPAT

0.8

8.4

690

8474

KCD32

NOMESCO Finland

Cystoscopic destruction of tumour of bladder

4.3

8.4

WX720

NOMESCO Finland

Own respiration

1.7

8.4

151

908

D75

ICPC

Malignant neoplasm colon/rectum

12.8

8.4

D37.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Stomach

4.9

8.4

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

6.7

8.3

9688/3-C77.8

ICD-O-3

T-cell/histiocyte rich large B-cell lymphoma of lymph nodes of multiple regions

+∞

8.3

ZX131

NOMESCO Finland

Intrathecal

+∞

8.3

C50.52

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor

+∞

8.3

3059, ,

Kela drug reimbursment

+∞

8.3

C83.41

ICD-10 Finland

Immunoblastic (diffuse)

+∞

8.3

JDD00

NOMESCO Finland

Total gastrectomy and Roux-en-Y oesophagojejunostomy

+∞

8.3

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

+∞

8.3

1532, ,

Kela drug reimbursment

+∞

8.3

2002A

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Burkitt's tumour or lymphoma

+∞

8.3

9698/3-C77.4

ICD-O-3

Follicular lymphoma, grade 3 of lymph nodes of inguinal region or leg

+∞

8.3

9659/3-C77.4

ICD-O-3

Hodgkin lymphoma, nodular lymphocyte predominant of lymph nodes of inguinal region or leg

+∞

8.3

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

+∞

8.3

JM2AT

NOMESCO Finland

Biopsy of spleen with ultrasound guidance

+∞

8.3

L01XE01

ATC

[U] imatinib

+∞

8.3

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

+∞

8.3

C23

ICD-10 Finland

Malignant neoplasm of gallbladder

+∞

8.3

PJ5AQ

NOMESCO Finland

Sentinell lymphnode SPECT with low dose CT

+∞

8.3

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

8.3

C03.1

ICD-10 Finland

Malignant neoplasm: Lower gum

+∞

8.3

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

+∞

8.3

9650/3-C77.3

ICD-O-3

Hodgkin lymphoma, NOS, of lymph nodes of axilla or arm

+∞

8.3

1DB01, ,

NOMESCO Finland

+∞

8.3

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

+∞

8.3

C83.4

ICD-10 Finland

Immunoblastic (diffuse) non-Hodgkin's lymphoma

+∞

8.3

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

8.3

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

+∞

8.3

1CD02, ,

NOMESCO Finland

+∞

8.3

C25.2

ICD-10 Finland

Malignant neoplasm: Tail of pancreas

+∞

8.3

C02.11

ICD-10 Finland

Malignant neoplasm of border of tongue

+∞

8.3

PJD91

NOMESCO Finland

Excision of lymph nodes in neck, 1 to 2 areas in total

+∞

8.3

9651/3-C77.8

ICD-O-3

Hodgkin lymphoma, lymphocyte-rich of lymph nodes of multiple regions

+∞

8.3

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

+∞

8.3

L01EM01

ATC

idelalisib; oral

+∞

8.3

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.2

8.2

296

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.0

8.2

423

R31

ICD-10 Finland

Unspecified haematuria

1.5

8.2

300

2119

OAB48

NOMESCO Finland

Lifestyle advice and guidance

4.2

8.2

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.7

8.1

148

893

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

33.4

8.1

C43.5

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of trunk

33.4

8.1

JCW98

NOMESCO Finland

Other transluminal endoscopic procedure on oesophagus

33.4

8.1

HA3AT

NOMESCO Finland

Pucture of mammary gland cyst with ultrasound examination

17.2

8.1

7842A

ICD-9 Finland

Symptoms involving head and neck, Swelling, mass, or lump in head and neck

11.7

8.1

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

4.0

8.1

Z29.9

ICD-10 Finland

Prophylactic measure, unspecified

3.3

8.1

D47.7

ICD-10 Finland

Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue

22.1

8.0

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.5

8.0

223

1490

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.5

8.0

213

1409

RS220, ,

NOMESCO Finland

2.8

8.0

136

QBA99

NOMESCO Finland

Other local destruction of skin of trunk

4.1

8.0

QXA50

NOMESCO Finland

Skin cryotherapy, unspecified location

4.3

7.9

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.4

7.9

900

P01AB01

ATC

metronidazole; oral, rectal

1.2

7.9

1115

9547

WX882

NOMESCO Finland

High dependency care

2.0

7.9

402

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

4.6

7.9

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

7.9

1294

11263

UDQ02

NOMESCO Finland

Direct laryngoscopy

3.4

7.8

K83.1

ICD-10 Finland

Obstruction of bile duct

3.2

7.8

WPA45

NOMESCO Finland

Continuous drug infusion in palliative care

10.8

7.8

SAA04

NOMESCO Finland

Special examination of mouth

1.7

7.8

138

827

R22.7

ICD-10 Finland

Localized swelling, mass and lump, multiple sites

9.4

7.8

N02BF02

ATC

pregabalin; oral

1.6

7.8

191

1242

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

2.5

7.7

179

A02BA02

ATC

ranitidine; systemic

1.3

7.7

584

4636

WPA16

NOMESCO Finland

Extensive demanding palliative symptom assessment and treatment

45.1

7.7

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

45.1

7.7

J02AC04

ATC

posaconazole; systemic

45.1

7.7

KAC10

NOMESCO Finland

Total nephrectomy with capsule

15.0

7.7

OAB42, ,

SPAT

0.7

7.7

217

3164

XF600

NOMESCO Finland

Bloodpressure measurement

1.6

7.7

178

1142

QXB05

NOMESCO Finland

Skin wound assessment, unspecified location

7.4

7.7

D11AH01

ATC

tacrolimus; topical

3.3

7.6

DAB00

NOMESCO Finland

Excision of lesion of auricle

3.7

7.6

JDE00

NOMESCO Finland

Gastrojejunostomy

18.4

7.6

ZXF10

NOMESCO Finland

Interruption caused by technical failure of equipment

18.4

7.6

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

7.6

372

2768

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

2.5

7.6

175

PJA01

NOMESCO Finland

Laparoscopic sentinel node excision

25.1

7.6

KC1GB

NOMESCO Finland

Cystography with X-ray

10.0

7.5

S29

ICPC

Skin symptom/complaint other

1.3

7.5

595

4751

UDC00

NOMESCO Finland

Ear microscopy

1.5

7.5

215

1446

A26

ICPC

Fear of cancer, NOS

4.2

7.5

UKC05

NOMESCO Finland

Cystoscopy and bladder biopsy

3.7

7.5

N06DA03

ATC

rivastigmine; oral, transdermal

0.5

7.4

1125

YN1BD

NOMESCO Finland

Extensive CT examination of extremities for dose design of radiotherapy

80.3

7.4

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

80.3

7.4

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

80.3

7.4

C44.01

ICD-10 Finland

Basocellular carcinoma of the lip skin

80.3

7.4

E28.8

ICD-10 Finland

Other ovarian dysfunction

80.3

7.4

M05BA02

ATC

clodronic acid; systemic

80.3

7.4

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

6.5

7.4

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.7

7.4

127

755

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.0

7.3

399

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

2.9

7.3

115

WE100

NOMESCO Finland

Profylactic cytostatic therapy

+∞

7.3

9714/3-C77.8

ICD-O-3

Anaplastic large cell lymphoma, T-cell and Null-cell type of lymph nodes of multiple regions

+∞

7.3

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

+∞

7.3

8130/3-C67.9

ICD-O-3

Papillary urothelial carcinoma of bladder, NOS

+∞

7.3

9689/3-C42.2

ICD-O-3

Splenic marginal zone B-cell lymphoma of spleen

+∞

7.3

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

7.3

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

+∞

7.3

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

+∞

7.3

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

7.3

L02BA03

ATC

fulvestrant; parenteral

+∞

7.3

C43.39

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face other or unspecified histology

+∞

7.3

JJB10

NOMESCO Finland

Atypcal resection of liver

+∞

7.3

X77

ICPC

Malignant neopl genital female other

+∞

7.3

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

7.3

C34.80

ICD-10 Finland

Malignant overall tumor of bronchus and lung without histology

+∞

7.3

L01BC59

ATC

trifluridine, combinations; systemic

+∞

7.3

C43.69

ICD-10 Finland

Malignant melanoma of the upper extremity including shoulder other or unspecified histology

+∞

7.3

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

+∞

7.3

C26.0

ICD-10 Finland

Malignant neoplasm: Intestinal tract, part unspecified

+∞

7.3

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

+∞

7.3

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

+∞

7.3

WD215

NOMESCO Finland

Multiple therapy of methastized malignancy with hormones

+∞

7.3

8090/3-C44.7

ICD-O-3

Basal cell carcinoma, NOS, of skin of lower limb and hip

+∞

7.3

9695/3-C77.2

ICD-O-3

Follicular lymphoma, grade 1 of intra-abdominal lymph nodes

+∞

7.3

9670/3-C77.3

ICD-O-3

Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of axilla or arm

+∞

7.3

PJ003

NOMESCO Finland

Adjuvant radiotherapy of neck, clavicle and axilla

+∞

7.3

JM1AT

NOMESCO Finland

Cytology of spleen with ultrasound guidance

+∞

7.3

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

7.3

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

7.3

17402

ICD-8 Finland

Malignant neoplasm of breast, Glandulae

+∞

7.3

8720/3-C44.6

ICD-O-3

Malignant melanoma, NOS, of skin of upper limb and shoulder

+∞

7.3

C38.1

ICD-10 Finland

Malignant neoplasm: Anterior mediastinum

+∞

7.3

PJ023

NOMESCO Finland

Adjuvant radiotherapy of mediastinal lymphnodes

+∞

7.3

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

+∞

7.3

EMB10

NOMESCO Finland

Tonsillectomy

1.8

7.3

112

645

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

2.3

7.3

234

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

3.8

7.2

K52.0

ICD-10 Finland

Gastroenteritis and colitis due to radiation

15.8

7.2

AA1AD

NOMESCO Finland

CT of head and brain

1.2

7.2

952

8079

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

5.8

7.2

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

2.9

7.2

116

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.4

7.2

210

ZXF00

NOMESCO Finland

Interruption caused by intraoperative deterioration of general condition

4.5

7.2

J35.1

ICD-10 Finland

Hypertrophy of tonsils

2.5

7.2

162

R53

ICD-10 Finland

Malaise and fatigue

1.3

7.1

756

6258

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.8

7.1

543

6752

GDC00

NOMESCO Finland

Lobectomy of lung

20.0

7.1

B44.0

ICD-10 Finland

Invasive pulmonary aspergillosis

20.0

7.1

HA1CM

NOMESCO Finland

Mammary gland extensive MRI examination with 3 Tesla magnet

20.0

7.1

UJC01

NOMESCO Finland

Scopy of lower throat

3.1

7.1

J01.4

ICD-10 Finland

Acute pansinusitis

3.3

7.1

EJA10

NOMESCO Finland

Biopsy of tongue or floor of mouth

2.2

7.1

256

S26

ICPC

Fear of cancer of skin

2.9

7.0

112

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

3.0

7.0

R93.3

ICD-10 Finland

Abnormal findings on diagnostic imaging of other parts of digestive tract

4.2

7.0

A02BX02

ATC

sucralfate; oral

1.7

7.0

117

691

ZZR10

NOMESCO Finland

Flap of skin and muscle

7.0

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

3.9

7.0

N63

ICD-10 Finland

Unspecified lump in breast

1.7

7.0

119

707

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

3.0

7.0

102

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.5

6.9

205

1391

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.7

6.8

109

635

D64.8

ICD-10 Finland

Other specified anaemias

2.2

6.8

260

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

6.8

1270

11150

D03.31

ICD-10 Finland

Melanoma in situ in another or unspecified part of the face

8.3

6.8

KE1DG

NOMESCO Finland

Very extensive MRI of prostate

3.8

6.8

BA2AT

NOMESCO Finland

Biopsy of thyroid with ultrasound quidance

10.9

6.8

D73.1

ICD-10 Finland

Hypersplenism

10.9

6.8

PJ2AE, ,

SPAT

10.9

6.8

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

6.8

495

3907

B34.9

ICD-10 Finland

Viral infection, unspecified

1.9

6.8

397

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

6.8

363

2740

XX9AQ

NOMESCO Finland

Supplementary SPECT-CT or additional scan

40.1

6.8

K11.2

ICD-10 Finland

Sialoadenitis

1.8

6.7

527

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

3.9

6.7

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

7.2

6.7

CAA30

NOMESCO Finland

Biopsy of orbit

22.5

6.7

R60.0

ICD-10 Finland

Localized oedema

1.3

6.6

386

2950

JJA20

NOMESCO Finland

Open biopsy of liver

7.8

6.6

C07AB07

ATC

bisoprolol; oral

1.2

6.6

1673

15106

RS221, ,

NOMESCO Finland

2.4

6.6

169

CBA10

NOMESCO Finland

Biopsy of eyelid

3.3

6.5

QB9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in torso, unspecified

4.2

6.5

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

10.0

6.5

JN5ER

NOMESCO Finland

PET-CT of receptors in whole body

10.0

6.5

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

2.8

6.5

106

B18.1

ICD-10 Finland

Chronic viral hepatitis B without delta-agent

6.8

6.5

I88.8

ICD-10 Finland

Other nonspecific lymphadenitis

6.2

6.5

C54.1

ICD-10 Finland

Malignant neoplasm: Endometrium

70.0

6.4

JN5AP

NOMESCO Finland

Total body PET (1 picture)

70.0

6.4

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

70.0

6.4

J02AC05

ATC

isavuconazole; systemic

70.0

6.4

C43.99

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin other or unspecified histology

70.0

6.4

WPA12

NOMESCO Finland

A meeting to support loved ones after the patient's death

70.0

6.4

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

70.0

6.4

WX199

NOMESCO Finland

Other local analgesia

1.7

6.4

107

632

D36.0

ICD-10 Finland

Benign neoplasm: Lymph nodes

14.3

6.4

RS222, ,

NOMESCO Finland

2.6

6.3

142

B37.7

ICD-10 Finland

Candidal sepsis

8.1

6.3

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

8.1

6.3

TQW80

NOMESCO Finland

Local dermatologic skincare

1.9

6.3

407

Y84.9

ICD-10 Finland

Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.6

6.3

ZZA00

NOMESCO Finland

Split skin graft

2.0

6.3

330

JN2BD

NOMESCO Finland

Extensive CT exmaniation of lower part of abdomen

11.0

6.3

KAD01

NOMESCO Finland

Percutaneous endoscopic partial nephrectomy

11.0

6.3

TQB05

NOMESCO Finland

Puncture of skin of trunk

5.5

6.3

2392A

ICD-9 Finland

Neoplasm of unspecified nature, Bone, soft tissue and skin

5.5

6.3

HA1BG

NOMESCO Finland

MRI examination of mammary gland with high intensity magnet

9.3

6.3

C10AX09

ATC

ezetimibe; oral

0.8

6.3

371

4779

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

2.6

6.3

137

Y84.8

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.3

6.3

J70.4

ICD-10 Finland

Drug-induced interstitial lung disorders, unspecified

18.0

6.3

GD2AT

NOMESCO Finland

Cytology of the lungs with ultrasound guidance

18.0

6.3

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

2.8

6.3

103

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

6.2

YL1CD

NOMESCO Finland

Very extensive CT examination of pelvis for dose design of radiotherapy

+∞

6.2

C24.9

ICD-10 Finland

Malignant neoplasm: Biliary tract, unspecified

+∞

6.2

Z85.8

ICD-10 Finland

Personal history of malignant neoplasms of other organs and systems

+∞

6.2

20018

ICD-8 Finland

Lymphosarcoma and reticulum-cell sarcoma, Lymphosarcoma loco non indicato sive generalisatum

+∞

6.2

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

6.2

9823/3-C77.3

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph nodes of axilla or arm

+∞

6.2

8140/3-C23.9

ICD-O-3

Adenocarcinoma, NOS, of gallbladder

+∞

6.2

M49.5*C79.5

ICD-10 Finland

Metastatic fracture of vertebra

+∞

6.2

9920/3-C42.1

ICD-O-3

Therapy-related myeloid neoplasm of bone marrow

+∞

6.2

JCC12

NOMESCO Finland

Thoracoscopic or laparoscopic partial oesophagectomy

+∞

6.2

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

6.2

316

Kela drug reimbursment

Imatinib

+∞

6.2

8070/3-C02.1

ICD-O-3

Squamous cell carcinoma, NOS, of border of tongue

+∞

6.2

9714/3-C77.9

ICD-O-3

Anaplastic large cell lymphoma, T-cell and Null-cell type of lymph node, NOS

+∞

6.2

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

6.2

L01AX03

ATC

temozolomide; systemic

+∞

6.2

C43.79

ICD-10 Finland

Malignant melanoma of the lower extremity including hip or other unspecified histology

+∞

6.2

9691/3-C77.3

ICD-O-3

Follicular lymphoma, grade 2 of lymph nodes of axilla or arm

+∞

6.2

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

6.2

1XC0R, ,

NOMESCO Finland

+∞

6.2

C44.59

ICD-10 Finland

Malignant tumor of the skin on the trunk other or unspecified histology

+∞

6.2

8140/3-C80.9

ICD-O-3

Adenocarcinoma, NOS, of unknown primary site

+∞

6.2

Z92.3

ICD-10 Finland

Personal history of irradiation

+∞

6.2

1BC01, ,

NOMESCO Finland

+∞

6.2

20228

ICD-8 Finland

Other neoplasms of lymphoid tissue, Other primary malignant neoplasms of lymphoid tissue

+∞

6.2

8070/3-C44.5

ICD-O-3

Squamous cell carcinoma, NOS, of skin of trunk

+∞

6.2

C18.2

ICD-10 Finland

Malignant neoplasm: Ascending colon

+∞

6.2

C43.70

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip without histology

+∞

6.2

C50.50

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication

+∞

6.2

9673/3-C77.3

ICD-O-3

Mantle cell lymphoma of lymph nodes of axilla or arm

+∞

6.2

9590/3-C77.8

ICD-O-3

Malignant lymphoma, NOS, of lymph nodes of multiple regions

+∞

6.2

L01XB01

ATC

procarbazine; oral

+∞

6.2

8070/3-C00.1

ICD-O-3

Squamous cell carcinoma, NOS, of external lower lip

+∞

6.2

8140/3-C16.9

ICD-O-3

Adenocarcinoma, NOS, of stomach, NOS

+∞

6.2

WF090

NOMESCO Finland

Profylactic radiotherapy

+∞

6.2

9962/3-C42.1

ICD-O-3

Essential thrombocythemia of bone marrow

+∞

6.2

UJC20

NOMESCO Finland

Extensive endoscopy to identify diagnosed or suspected primary malignant neoplasm of head or neck

+∞

6.2

3019

Kela drug reimbursment

Lenvatinib

+∞

6.2

C50.5

ICD-10 Finland

Malignant neoplasm: Lower-outer quadrant of breast

+∞

6.2

J17.1*B25.0

ICD-10 Finland

Cytomegaloviral pneumonitis

+∞

6.2

V03AB28, ,

ATC

+∞

6.2

9670/3-C77.4

ICD-O-3

Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of inguinal region or leg

+∞

6.2

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

6.2

J05AX18

ATC

letermovir; oral

+∞

6.2

L01EF01

ATC

palbociclib; oral

+∞

6.2

3AF07, ,

NOMESCO Finland

+∞

6.2

4CJ01, ,

NOMESCO Finland

+∞

6.2

L01EA01

ATC

imatinib; oral

+∞

6.2

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

+∞

6.2

9673/3-C77.4

ICD-O-3

Mantle cell lymphoma of lymph nodes of inguinal region or leg

+∞

6.2

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

+∞

6.2

9673/3-C77.0

ICD-O-3

Mantle cell lymphoma of lymph nodes of head, face and neck

+∞

6.2

J70.1

ICD-10 Finland

Chronic and other pulmonary manifestations due to radiation

+∞

6.2

1CA02, ,

NOMESCO Finland

+∞

6.2

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

6.2

2017X

ICD-9 Finland

Hodgkin's disease, Lymphocytic depletion[MORBUS HODGKIN, LYMPHOCYTIC DEPLETION NUD]

+∞

6.2

1508

Kela drug reimbursment

Lenvatinib

+∞

6.2

9651/3-C77.3

ICD-O-3

Hodgkin lymphoma, lymphocyte-rich of lymph nodes of axilla or arm

+∞

6.2

C50.2

ICD-10 Finland

Malignant neoplasm: Upper-inner quadrant of breast

+∞

6.2

C49.20

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology

+∞

6.2

2014X

ICD-9 Finland

Hodgkin's disease, Lymphocytic-histiocytic predominance[MORBUS HODGKIN,LYMPHOCYTIC PREDOMINANCE"""",NUD]

+∞

6.2

9680/3-C80.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of unknown primary site

+∞

6.2

8522/3-C50.9

ICD-O-3

Infiltrating duct and lobular carcinoma of breast, NOS

+∞

6.2

J01AA02

ATC

doxycycline; systemic

1.2

6.2

2514

23605

GA2AT

NOMESCO Finland

Pleural biopsy with ultrasound guidance

26.7

6.2

6830A

ICD-9 Finland

Acute lymphadenitis[LYMPHADENITIS ACUTA COLLI]

26.7

6.2

J01FA06

ATC

roxithromycin; oral

1.2

6.2

1151

10081

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

3.0

6.2

Z51.4

ICD-10 Finland

Preparatory care for subsequent treatment, not elsewhere classified

2.9

6.2

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.7

6.2

114

692

S21

ICPC

Skin texture symptom/complaint

1.3

6.2

436

3426

Z12.5

ICD-10 Finland

Special screening examination for neoplasm of prostate

3.2

6.1

A46

ICD-10 Finland

Erysipelas

1.3

6.1

468

3715

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

1.7

6.1

107

641

XF602

NOMESCO Finland

Bloodpressure monitoring

2.4

6.1

163

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

4.1

6.1

JG1BG

NOMESCO Finland

MRI of rectum

10.0

6.0

EMA30

NOMESCO Finland

Biopsy of rhinopharynx

10.0

6.0

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.1

6.0

261

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

6.0

757

6378

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

703

1539

5.41

310.12

2.9

1.5

13.63

2.72

ug/l

2.87

543

1141

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

322

107

32.87

307.65

1.6

1.5

3.48

4.20

mg/l

1.08

316

102

(3024561) Albumin [Mass/volume] in Serum or Plasma

2678

13543

4.55

307.65

8.5

4.1

34.53

35.79

g/l

23.49

2607

12514

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

448

396

12.74

307.65

1.3

1.2

—

(3002030) Lymphocytes/Leukocytes in Blood

2914

14302

5.90

307.65

11.6

5.9

26.36

27.46

4.55

2856

13437

(3027945) Reticulocytes/Erythrocytes in Blood

1179

3718

4.19

307.65

3.7

2.2

1.75

1.78

0.35

1102

3265

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

297

139

23.15

307.65

2.9

1.9

0.48

0.74

e9/l

4.78

281

132

(3019069) Monocytes/Leukocytes in Blood

2912

14017

6.07

307.65

11.6

6.0

9.67

9.02

20.44

2847

13000

(1175426) CD3 cells/Lymphocytes in Blood

423

128

37.19

307.65

2.3

1.7

73.19

72.14

0.33

405

118

(3004809) Band form neutrophils/Leukocytes in Blood

363

354

11.26

307.65

4.7

2.4

1.74

1.22

1.13

345

300

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

698

268.66

307.65

1.4

1.1

—

(3045142) Bone marrow Pathology biopsy report

676

134

61.51

307.65

1.5

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1631

1849

15.00

307.65

1.4

1.5

—

(3019198) Lymphocytes [#/volume] in Blood

3028

15750

6.10

307.65

11.2

5.8

1.93

1.86

e9/l

0.47

2791

13697

(3005719) IgG [Mass/volume] in Serum or Plasma

1211

2131

7.96

307.65

4.2

2.3

8.78

10.78

g/l

37.34

1170

1967

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

335

127

28.91

307.65

3.0

1.8

221.32

221.01

e6/l

0.01

282

109

(3001604) Monocytes [#/volume] in Blood

3015

15381

6.21

307.65

11.0

5.8

0.62

0.60

e9/l

2.38

2737

13072

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2990

15222

6.04

307.65

16.3

4.0

10.51

12.12

umol/l

9.55

2956

14310

(3006504) Eosinophils/Leukocytes in Blood

2904

13994

6.01

307.65

11.4

5.9

2.71

2.97

8.46

2839

12976

(3006315) Basophils [#/volume] in Blood

3016

15451

6.17

307.65

11.1

5.8

0.04

e9/l

5.11

2740

13142

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2497

2999

23.57

307.65

8.3

2.4

260.17

232.36

u/l

11.65

2437

2794

(3028026) IgM [Mass/volume] in Serum or Plasma

868

1678

6.45

307.65

3.0

1.5

1.11

1.16

g/l

0.36

818

1537

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1452

4786

4.35

307.65

6.7

2.8

0.81

0.82

mmol/l

6.41

1421

4438

(3042111) Morphology [Interpretation] in Bone marrow Narrative

636

278

27.42

307.65

1.6

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

428

121

39.87

307.65

2.3

1.7

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

614

467

15.57

307.65

5.1

5.8

386.04

442.62

iu/ml

0.17

(40765096) Chromosome analysis panel by Banding

325

114.85

307.65

1.2

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1927

4413

8.03

307.65

1.7

1.8

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

327

130

27.50

307.65

2.7

1.8

551.06

442.32

e6/l

1.45

259

104

(40768795) Lymph node Pathology biopsy report

1146

352.92

307.65

1.5

1.1

—

(3018010) Neutrophils/Leukocytes in Blood

2870

14088

5.64

307.65

10.8

5.9

57.15

57.56

0.87

2831

13358

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

488

518

10.70

307.65

1.4

1.5

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

483

516

10.62

307.65

1.4

1.5

21.60

13.52

u/ml

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

488

632

8.74

307.65

1.6

1.5

—

(3013115) Eosinophils [#/volume] in Blood

3040

15953

6.10

307.65

11.9

5.9

0.18

0.20

e9/l

15.60

2785

13760

(4035726) Immunohistochemistry procedure

1452

825

28.34

307.65

1.8

1.3

—

(21494814) CD8 cells/Lymphocytes in Specimen

228

39.13

307.65

2.2

1.9

37.21

25.10

9.59

228

(3017143) Hepatitis C virus Ab [Presence] in Serum

1729

2949

10.14

307.65

1.5

1.6

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

316

34.81

307.65

3.6

2.3

34.06

45.65

6.95

218

(3011412) CD3 cells [#/volume] in Blood

519

172

34.94

307.65

2.6

1.9

1025.91

1155.49

e6/l

1.11

464

148

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1844

3644

9.10

307.65

1.6

—

(3022096) Basophils/Leukocytes in Blood

2897

14010

5.93

307.65

11.5

6.0

0.68

0.67

0.21

2828

12981

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

586

351

19.65

307.65

2.8

2.9

8765.02

583.05

u/ml

1.31

(3017181) Myelocytes/Leukocytes in Blood

954

2572

4.65

307.65

6.4

4.0

1.05

0.70

3.65

632

535

(3010503) CD19 cells [#/volume] in Blood

331

112

32.36

307.65

2.7

2.0

301.68

141.04

e6/l

0.49

325

105

(3026493) Urate [Moles/volume] in Serum or Plasma

2225

8496

5.07

307.65

5.9

2.5

318.71

355.71

umol/l

46.94

2164

7342

(3013650) Neutrophils [#/volume] in Blood by Automated count

3111

16482

6.60

307.65

25.4

6.6

3.64

4.29

e9/l

53.82

2881

13993

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

442

455

10.90

307.65

1.4

1.5

127.18

150.49

au/ml

2.40

121

156

(3023368) Bacteria identified in Blood by Culture

1897

8527

3.52

306.83

7.9

4.0

—

(3023520) Reticulocytes [#/volume] in Blood

989

2897

4.30

303.33

3.9

2.1

68.79

68.71

e9/l

0.02

782

2147

(3006245) CD3-CD19+ cells/cells in Blood

196

31.79

300.62

2.3

1.7

8.54

9.37

0.26

175

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

452

678

7.46

292.59

2.2

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

457

699

7.32

290.55

2.3

1.4

—

(3002179) Metamyelocytes/Leukocytes in Blood

881

2471

4.37

284.86

6.4

3.7

0.71

0.54

1.70

565

525

(3021440) Promyelocytes/Leukocytes in Blood

877

2500

4.29

276.85

6.5

4.0

0.16

0.05

5.49

552

465

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

359

443

8.87

274.23

2.3

1.4

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

159

36.88

255.18

3.0

1.6

46.62

47.49

u/l

0.01

154

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2664

15888

3.42

250.20

11.6

6.4

1.22

1.21

mmol/l

10.60

2327

13660

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1117

4045

3.52

245.85

7.3

6.0

1.04

mmol/l

0.10

1084

3718

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2456

14122

3.20

242.29

9.8

6.1

1.22

1.21

mmol/l

10.40

2388

12829

(3015377) Calcium [Moles/volume] in Serum or Plasma

1972

10079

3.05

239.36

7.8

2.1

2.36

2.35

mmol/l

0.94

1883

8855

(3025159) Blasts/Leukocytes in Blood

825

2560

3.86

227.72

6.8

4.2

0.10

0.01

1.59

493

447

(3004588) Protein electrophoresis panel - Serum or Plasma

776

2311

3.98

227.17

1.9

1.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

341

495

7.49

226.10

1.3

272.82

255.95

u/ml

0.40

204

303

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2325

13282

3.02

225.70

4.3

2.5

—

estimate

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

494

1038

5.34

225.23

2.5

2.9

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

230

202

12.08

224.06

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

426

789

5.97

222.85

1.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1297

5418

3.15

222.19

2.8

1.8

—

(3020630) Protein [Mass/volume] in Serum or Plasma

835

2710

3.69

214.63

2.6

1.6

64.09

66.61

g/l

12.85

806

2444

(40768804) Tissue Pathology biopsy report

1855

9577

2.88

214.07

2.7

1.7

—

(3000060) B lymphocytes [#/volume] in Blood

136

30.00

205.36

2.1

1.6

0.10

0.19

e9/l

1.32

(40760892) CBC W Ordered Manual Differential panel - Blood

1402

6391

2.92

201.91

9.3

4.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

223

220

10.72

200.70

4.4

2.9

—

(3018418) pH of Serum or Plasma

1783

9241

2.80

200.68

7.4

3.5

7.40

8.26

1355

6576

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

358

628

6.20

197.53

1.8

1.3

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3237

23249

4.15

196.93

21.4

5.9

84.91

76.76

u/l

16.17

3182

21720

(3002256) Pathology report gross observation

752

2402

3.67

196.66

1.4

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

1741

9016

2.76

194.71

4.1

2.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

330

553

6.45

190.50

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

324

537

6.52

189.05

1.8

1.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1321

6049

2.84

185.81

5.0

2.2

2.48

2.44

mmol/l

13.94

1285

5325

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

281

428

7.02

177.60

1.9

1.3

—

(3017354) Segmented neutrophils/Leukocytes in Blood

220

253

9.18

176.64

4.9

2.3

53.38

59.68

3.00

205

206

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

132

21.35

175.64

4.2

3.1

1.46

1.10

0.56

132

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

211

242

9.19

169.70

2.5

2.4

26.33

40.98

iu/ml

0.59

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

655

2104

3.57

168.03

2.2

1.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

210

245

9.03

166.64

2.5

1.4

—

(3032080) INR in Blood by Coagulation assay

2354

14944

2.58

162.75

16.3

18.1

1.24

1.33

inr

12.65

2000

12543

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

214

267

8.45

160.86

2.5

1.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

980

4090

2.90

160.76

2.5

1.8

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

298

540

5.91

158.34

1.9

1.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

235

334

7.45

157.98

1.9

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

239

352

7.19

155.55

1.9

1.4

—

(3042936) Bacteria identified in Isolate by Culture

1004

4332

2.81

153.84

2.0

2.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

924

3826

2.89

152.93

2.6

1.8

—

(3021589) Normoblasts [#/volume] in Blood

2168

13500

2.47

152.17

20.8

10.2

0.00

e9/l

1.64

1818

10992

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

461

1249

4.07

150.77

2.3

1.7

1.62

1.66

ug/l

0.03

420

1089

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1352

6867

2.53

147.83

3.9

2.2

—

(40758292) HTLV I+II Ab panel - Serum

36.87

144.67

1.5

1.1

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

3081

23168

2.98

137.57

7.5

4.5

15.21

11.97

mm/h

20.80

2987

21586

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

288

586

5.25

134.47

2.4

2.0

262.35

229.93

u/ml

0.05

225

471

(3000012) Reticulocyte production index

241

419

6.08

133.33

3.0

1.6

0.94

0.88

0.78

183

267

(3007164) IgA [Mass/volume] in Serum or Plasma

1176

5828

2.49

133.04

2.4

1.4

1.99

2.56

g/l

14.23

930

3427

(3033658) Prothrombin time (PT) actual/Normal

1374

7322

2.39

132.10

6.0

3.8

87.95

86.18

1.87

1359

7151

(3032352) Blasts [#/volume] in Cerebral spinal fluid

51.01

130.17

1.7

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

113

14.36

123.94

2.1

2.6

8022.05

3054.79

u/ml

0.46

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

161

195

8.59

123.73

1.2

1.3

83.24

79.67

0.23

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

168

217

8.06

122.43

2.5

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

168

217

8.06

122.43

2.5

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

168

217

8.06

122.43

2.5

1.3

—

(3042631) Mycobacterium sp identified in Specimen

217

383

5.96

118.05

2.2

3.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

36.70

115.56

1.2

1.3

—

(3037756) Immunofixation for Serum or Plasma

273

603

4.81

115.48

1.3

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

105

14.38

115.35

3.0

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

118

108

11.25

111.35

2.8

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

118

108

11.25

111.35

2.8

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

118

108

11.25

111.35

2.8

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

118

108

11.25

111.35

2.8

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

103

13.91

111.07

3.0

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

103

13.91

111.07

3.0

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

109

12.45

109.90

1.2

1.3

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

989

4911

2.38

107.93

3.0

2.0

29.57

29.78

0.46

976

4778

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

180

290

6.47

107.24

1.3

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

740

3221

2.62

107.24

5.3

2.3

8.19

7.65

umol/l

0.29

676

2789

(3003694) ABO and Rh group [Type] in Blood

1386

7987

2.18

105.09

1.6

1.4

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2565

18697

2.21

104.75

7.6

4.8

6.61

6.81

mmol/l

5.80

2504

17670

(40758558) Short blood count panel - Blood

1498

8917

2.14

104.28

16.0

4.7

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

129

151

8.82

101.76

2.0

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

125

145

8.89

99.30

2.0

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

133

168

8.17

98.63

2.0

1.3

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

287

744

4.10

98.59

3.1

2.5

3.86

3.53

g/l

2.17

279

708

(44806118) Parainfluenza type 4 nucleic acid detection

192

358

5.60

98.39

1.8

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

192

358

5.60

98.39

1.8

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

192

358

5.60

98.39

1.8

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

192

358

5.60

98.39

1.8

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

443

1537

3.14

97.54

1.8

1.7

1.65

1.53

g/l

1.46

366

1330

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

148

215

7.13

97.17

2.1

1.4

—

(21494434) Karyotype in Bone marrow

123

148

8.56

94.90

1.1

—

(3035933) Granulocytes/Leukocytes in Blood

234

535

4.60

94.62

5.5

3.2

57.52

57.76

0.09

234

535

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

108

112

9.90

93.35

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

108

112

9.90

93.35

1.5

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

900

4664

2.23

86.18

2.5

2.8

22.25

22.68

0.28

860

4292

(3002582) Erythrocytes [#/volume] in Urine

1591

10230

1.97

84.78

3.9

3.2

32.44

63.72

e6/l

2.69

1251

7779

(3030467) Casts [#/volume] in Urine by Automated count

1420

8780

2.00

84.70

3.8

3.1

0.52

0.44

e6/l

0.40

1081

6409

(3016650) Hepatitis A virus Ab [Presence] in Serum

202

449

4.70

84.47

1.1

—

(40768806) Pleura Pathology biopsy report

146

244

6.19

83.77

1.8

1.4

—

(36304419) Bacteria [Presence] in Urine

1357

8296

2.00

83.26

3.7

3.1

0.00

261.48

estimate

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

576

2507

2.54

81.76

2.3

2.1

0.19

0.20

g/l

4.08

542

2294

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

18.36

81.19

1.2

1.3

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1650

10887

1.93

80.11

4.0

3.3

1806.32

1501.16

ng/l

1.99

1485

9420

(3004789) Transferrin [Mass/volume] in Serum or Plasma

941

5101

2.13

79.55

2.5

2.7

2.20

2.30

g/l

5.99

885

4663

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

19.99

79.18

1.6

2.4

25653.57

1040.00

u/ml

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

384

1402

2.94

76.62

1.7

1.4

4.04

4.21

g/l

1.41

365

1252

(40768793) Breast Pathology biopsy report

118

174

6.97

76.35

1.4

1.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

383

1400

2.94

76.24

1.7

1.4

3.54

3.73

g/l

0.89

364

1248

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

173

368

4.88

76.22

2.7

2.1

742.21

25.68

u/ml

0.69

149

329

(3018095) Leukocytes [#/volume] in Urine

1715

11597

1.89

76.00

4.6

3.8

120.72

110.62

e6/l

0.12

1286

8107

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

383

1404

2.93

75.83

1.7

1.4

7.37

7.47

g/l

0.48

363

1252

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

543

2391

2.49

74.76

8.4

3.1

1.23

mmol/l

1.68

525

2014

(3017732) Neutrophils [#/volume] in Blood

752

3816

2.22

74.62

4.2

2.9

4.87

4.67

e9/l

0.15

655

3241

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

339

1192

3.03

72.20

1.8

1.5

0.51

0.37

g/l

0.50

295

1023

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

304

1009

3.19

71.47

1.7

1.4

0.02

0.01

g/l

0.37

280

916

(3022948) Iron [Moles/volume] in Serum or Plasma

963

5467

2.03

70.69

2.5

2.7

12.09

12.94

umol/l

2.65

916

5038

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

132

239

5.69

69.67

1.4

1.3

330.59

314.55

u/l

0.09

124

224

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

355

1315

2.88

68.75

1.8

1.4

3.18

2.90

g/l

4.70

336

1165

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

236

684

3.62

68.74

1.3

109.54

215.73

miu/ml

3.57

294

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

460

1951

2.55

68.25

2.1

1.7

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2574

20212

1.90

67.44

5.6

4.6

504.29

2117.99

e6/l

1.84

296

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

289

967

3.16

66.93

1.7

1.4

0.00

g/l

-0.00

259

856

(3000991) Gas panel - Venous blood

582

2768

2.31

66.90

8.0

9.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

151

322

4.85

66.29

1.7

1.5

1734.60

2166.24

e6/l

0.25

107

223

(3020779) Urea [Moles/volume] in Serum or Plasma

605

2941

2.26

65.95

8.0

7.6

10.31

10.82

mmol/l

0.80

588

2797

(3008536) Aspergillus sp Ab [Presence] in Serum

14.17

65.62

2.7

1.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

334

1228

2.89

65.49

1.7

1.4

8.99

10.20

g/l

4.28

313

1071

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

278

924

3.17

65.08

1.6

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

261

841

3.26

64.32

1.8

1.7

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

312

1116

2.96

64.28

2.0

1.5

51.08

47.71

mg/l

0.32

255

945

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

106

168

6.47

64.03

1.7

1.4

15.73

13.57

u/l

1.09

101

160

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

311

1113

2.96

64.00

2.0

1.5

35.89

35.66

mg/l

0.02

253

936

(3028308) Erythrocytes [#/volume] in Pleural fluid

138

284

5.01

63.16

1.6

1.5

32779.27

57538.82

e6/l

0.44

156

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

248

786

3.31

62.76

1.9

2.1

12.24

11.75

mg/l

0.38

236

727

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

286

987

3.06

62.74

2.0

1.5

2.61

1.62

ratio

1.23

162

572

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

259

844

3.22

62.63

3.2

1.5

95.88

25.72

u/ml

4.12

253

804

(3000093) Morphology [Interpretation] in Blood Narrative

135

275

5.06

62.52

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

170

424

4.15

61.20

5.4

6.3

11.19

12.24

mg/l

2.14

156

392

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

138

292

4.87

61.13

1.2

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

269

916

3.09

60.35

1.7

1.5

0.00

g/l

-0.00

259

854

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

340

1324

2.73

59.64

1.9

43.00

38.99

u/l

2.58

311

1147

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

854

4905

1.96

59.18

3.4

3.0

1.73

2.39

e6/l

1.64

426

2360

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

103

172

6.13

59.09

1.4

1.2

19.67

9.87

u/l

1.61

150

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

274

967

2.98

57.69

3.5

3.3

0.35

0.34

iu/ml

0.13

164

553

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

106

189

5.74

56.85

2.1

1.2

3.20

3.11

ug/l

0.03

166

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

387

1646

2.51

56.64

1.8

1.5

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1293

8564

1.78

56.59

2.3

2.4

3.15

2.76

mg/l

5.68

1140

7362

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

173

463

3.87

56.50

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

14.89

56.23

1.7

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

19.76

55.51

6.7

1.2

19.09

66.46

ug/l

1.38

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

137

6.63

55.28

1.3

1.1

—

(3026782) Osmolality of Urine

973

5948

1.86

55.22

3.2

2.8

528.85

534.50

mosm/kgh2o

0.36

886

5185

(3028433) Virus identified in Specimen by Culture

8.32

54.78

1.5

1.1

—

(3000494) Fungus identified in Specimen by Culture

683

3759

2.00

52.86

1.7

1.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

309

1223

2.67

52.32

3.1

1.8

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

903

5478

1.86

52.05

3.4

2.8

0.99

1.13

e6/l

0.54

475

2952

(3002032) Base excess in Venous blood by calculation

633

3430

2.02

51.03

4.9

3.7

2.03

1.84

mmol/l

0.63

564

3003

(3000850) Epithelial cells [#/volume] in Urine

1099

7119

1.77

50.76

3.1

2.6

4.75

5.01

e6/l

0.28

1024

6446

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1422

9902

1.71

50.70

3.3

2.4

55.10

60.46

u/l

2.15

1335

9115

(3012544) pH of Venous blood

646

3566

1.98

49.26

4.9

3.7

7.38

0.60

401

2048

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

145

5.98

47.72

1.3

1.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

634

3515

1.97

47.60

4.9

3.7

5.77

5.84

kpa

1.06

627

3423

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

459

2275

2.16

46.68

4.8

3.9

5.04

5.16

kpa

2.44

450

2167

(3009343) pH of Capillary blood

448

2204

2.18

46.41

4.9

3.9

7.43

7.41

5.10

393

1823

(3045788) Cell count panel - Pleural fluid

113

258

4.49

45.61

1.7

1.5

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

519

2724

2.05

45.30

2.8

1.8

382.99

367.30

nmol/l

0.99

492

2495

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1037

6786

1.73

45.27

2.0

1.8

1.91

1.22

mg/l

3.05

849

5219

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

232

853

2.83

45.17

5.1

3.4

1.52

1.68

mg/l

2.02

223

754

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1391

9878

1.65

44.47

6.3

2.7

34.22

35.46

u/l

0.23

1340

9235

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

276

1132

2.55

43.30

2.3

1.7

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

113

269

4.30

43.24

3.1

3.0

—

(3019225) pH of Specimen

555

3033

1.98

43.11

7.3

3.8

7.38

7.35

3.69

499

2001

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

8.06

43.07

1.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

397

1919

2.20

42.84

4.8

3.8

2.31

1.80

mmol/l

1.94

322

1386

(3026008) Bacteria identified in Urine by Culture

1325

9404

1.64

41.79

3.4

3.3

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

144

419

3.54

41.57

2.8

1.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

559

3115

1.94

40.85

5.3

3.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

198

712

2.88

40.13

1.7

1.4

11.83

8.28

u/l

2.32

150

576

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3321

30057

2.03

37.17

39.4

14.9

25.96

24.31

mg/l

2.27

3129

24438

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

7.70

36.53

1.7

1.1

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

7.35

36.45

1.8

1.4

1.65

2.83

0.56

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

13.19

35.70

1.2

2.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

974

6605

1.64

35.69

4.8

4.2

423.00

453.71

ng/l

0.06

839

5414

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

213

4.35

35.61

1.4

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

10.67

33.99

1.2

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

487

2745

1.89

33.98

2.7

2.3

36.55

38.61

u/l

0.28

412

2289

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1667

12908

1.53

33.96

4.9

4.0

39.99

81.69

ng/l

1.47

1380

9478

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1795

14127

1.53

33.85

3.4

3.1

328.95

126.57

ug/l

19.01

1683

13078

(3005532) Lymphocytes/Leukocytes in Pleural fluid

6.23

33.03

1.8

1.3

66.23

60.99

0.42

(3019832) Treponema pallidum Ab [Presence] in Serum

398

2117

1.99

32.94

1.5

1.7

—

(40768800) Prostate Pathology biopsy report

168

4.66

32.91

1.2

—

(3022313) Gas panel - Capillary blood

318

1561

2.13

32.73

5.3

4.1

—

(3035880) pH of Pleural fluid

127

5.27

32.64

1.5

1.3

7.42

7.45

0.54

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

233

1007

2.40

32.53

1.5

0.31

3.49

iu/ml

0.47

185

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

9.59

32.39

3.7

6.3

9.74

7.53

0.91

(40761995) Spermatozoa Progressive [#/volume] in Semen

9.59

32.39

1.9

3.1

38.89

47.07

1.05

(1617658) Protocol used for examination of sentinel lymph nodes

+∞

32.33

1.0

0.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

200

808

2.56

32.28

1.7

1.4

25.72

25.38

iu/l

0.04

151

688

(3025468) Yersinia sp identified in Specimen by Organism specific culture

113

337

3.43

31.43

2.4

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

208

873

2.47

30.96

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

112

337

3.40

30.73

2.4

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

112

340

3.37

30.31

2.4

1.3

—

(3012501) Base excess in Blood by calculation

158

592

2.74

29.63

5.2

4.3

2.89

2.57

mmol/l

0.69

124

391

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

204

869

2.43

29.39

2.0

1.3

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1793

14381

1.48

29.15

2.5

2.4

75.26

78.06

nmol/l

4.14

1673

12772

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

113

354

3.26

29.08

2.4

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

114

360

3.24

28.96

2.4

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

113

357

3.23

28.69

2.4

1.3

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

+∞

28.16

1.1

0.0

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

119

5.02

27.70

2.1

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

119

5.02

27.70

2.1

1.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

11.23

27.56

1.9

1.2

130.67

127.30

ng/l

0.03

(3025941) Bacteria identified in Stool by Culture

300

1540

2.03

27.29

1.4

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

7.94

27.25

1.4

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

175

720

2.50

27.18

1.8

1.3

80.95

27.35

e6/l

0.55

125

536

(1616796) Gas panel - Central venous blood

169

686

2.53

27.00

4.6

4.0

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

175

731

2.46

26.31

1.8

1.4

512.70

774.90

e6/l

0.22

136

580

(40768443) Skin Pathology biopsy report

253

1238

2.12

26.15

1.3

1.2

—

(3003396) Base excess in Arterial blood by calculation

586

3760

1.66

25.67

7.5

7.7

1.13

1.09

mmol/l

0.10

486

3086

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

248

1217

2.11

25.44

5.7

4.1

25.59

24.74

mmol/l

4.48

238

1119

(3019977) pH of Arterial blood

586

3772

1.66

25.33

7.7

7.8

7.43

7.42

2.17

316

2162

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

158

643

2.52

25.12

1.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

570

3652

1.66

25.07

1.9

1.8

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

23.54

24.76

1.3

1.1

—

(3027801) Oxygen [Partial pressure] in Arterial blood

584

3788

1.64

24.42

7.5

7.7

12.29

11.58

kpa

2.32

562

3642

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

105

5.01

24.40

6.2

1.1

51.16

55.99

u/ml

0.05

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

584

3789

1.64

24.40

7.5

7.8

5.02

5.06

kpa

0.43

557

3646

(3042010) Triglyceride [Moles/volume] in Pleural fluid

8.27

24.37

1.3

5.06

1.75

mmol/l

0.88

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

187

836

2.30

24.15

1.7

1.2

578.94

506.02

mg/l

0.88

177

787

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

179

788

2.34

23.96

2.7

2.4

214.85

189.30

3.14

173

747

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

5.97

23.85

1.4

1.2

5.03

5.12

ug/l

0.01

(3014148) Varicella zoster virus Ab [Titer] in Serum

104

352

3.01

23.54

1.2

1.1

—

(3016502) Oxygen saturation in Arterial blood

531

3403

1.65

23.20

7.8

8.0

95.53

95.01

1.08

513

3288

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

110

389

2.88

23.03

1.2

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2028

17094

1.41

22.78

3.2

2.7

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

175

3.88

22.73

2.0

1.6

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

286

3.20

22.68

1.7

1.4

0.29

nmol/l

0.04

234

(40768441) Liver Pathology biopsy report

116

4.62

22.63

1.4

1.6

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

151

634

2.44

22.47

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

151

634

2.44

22.47

1.5

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

180

3.77

21.86

2.0

1.3

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

3156

29031

1.60

21.69

35.1

14.5

78.36

78.00

ml/min/173m2

0.42

3015

26719

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

177

3.78

21.59

2.0

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

347

2.90

21.09

1.7

1.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2277

19726

1.40

20.94

4.2

3.2

59.21

47.41

u/l

5.94

2156

18285

(3010375) cycloSPORINE [Mass/volume] in Blood

108

4.58

20.76

40.5

27.6

118.73

119.20

ug/l

0.02

(40768797) Stomach Pathology biopsy report

630

4323

1.55

20.48

1.3

1.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

482

3116

1.63

20.18

8.5

8.6

114.33

122.54

g/l

13.70

471

3051

(3028192) IgG subclass 2 [Mass/volume] in Serum

303

2.99

19.99

1.4

2.33

2.97

g/l

1.97

220

(3027135) IgG subclass 1 [Mass/volume] in Serum

303

2.99

19.99

1.4

6.53

7.01

g/l

0.38

222

(3024139) IgG subclass 3 [Mass/volume] in Serum

303

2.99

19.99

1.4

0.39

0.38

g/l

0.08

223

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

+∞

19.80

1.0

0.0

—

(3036489) Thrombin time

212

1077

2.03

19.80

2.4

2.0

22.40

20.86

1.26

201

959

(4062490) Immunoglobulin typing, IgG

297

2.98

19.45

1.4

—

(3044889) 12 lead EKG panel

2469

21808

1.40

19.43

5.3

4.3

0.67

8241.06

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

6.32

19.27

1.2

1.3

1.35

1.56

mmol/l

0.36

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

236

3.22

19.26

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

159

737

2.21

18.86

1.7

1.2

3.82

3.88

mmol/l

0.27

146

696

(3024980) IgG subclass 4 [Mass/volume] in Serum

121

498

2.48

18.84

1.4

1.6

0.59

0.90

g/l

2.26

391

(3049717) Cytology report of Urine Cyto stain

197

995

2.04

18.70

2.8

1.8

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

5.04

18.54

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

123

517

2.43

18.31

1.3

1.2

113.85

18.73

u/l

2.27

109

441

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

7.15

18.22

1.9

1.4

12.86

8.96

0.26

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

7.27

17.79

1.6

1.3

99.16

140.83

ng/l

0.22

(3009871) Measles virus Ab [Titer] in Serum

106

4.29

17.58

1.9

1.5

3565.71

3697.14

titre

0.03

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

146

673

2.22

17.57

1.5

1.6

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

2726

24661

1.40

17.37

44.0

18.0

14.32

13.59

108.85

2713

24264

(40761536) Microorganisms panel - Urine sediment

364

2273

1.67

17.36

4.8

3.9

—

(3024354) Oxygen [Partial pressure] in Venous blood

453

2989

1.59

17.29

4.3

3.1

4.69

4.55

kpa

0.61

444

2902

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

227

1239

1.89

17.20

1.2

1.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

184

935

2.02

17.18

1.5

1.6

1.20

1.19

g/l

0.14

177

883

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

439

2885

1.59

17.03

3.4

3.3

272.89

213.43

ng/l

1.65

413

2656

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

180

914

2.02

16.85

1.5

1.6

0.24

0.23

g/l

0.36

168

869

(3023419) Bacteria identified in Sputum by Culture

110

457

2.45

16.82

2.0

2.7

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

3314

31200

1.60

16.59

38.9

18.7

139.33

139.79

mmol/l

21.41

3279

30541

(3037121) Protein [Mass/volume] in Urine

194

1019

1.95

16.50

2.5

2.8

486.64

416.85

mg/l

0.18

101

387

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

296

1778

1.72

16.30

11.1

10.6

15.29

16.08

5.53

284

1721

(3006184) Hemoglobin [Mass/volume] in Capillary blood

165

822

2.05

16.28

2.9

2.2

119.62

132.03

g/l

6.68

122

645

(3023103) Potassium [Moles/volume] in Serum or Plasma

3314

31261

1.58

15.74

39.6

18.8

3.99

mmol/l

0.05

3277

30539

(4281824) Cell count and differential, peritoneal fluid

159

3.43

15.47

1.1

—

(3015736) pH of Urine

1598

13483

1.33

15.22

3.9

3.5

6.22

6.25

0.49

849

7360

(3010937) Rubella virus Ab [Presence] in Serum

17.79

15.13

1.0

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

297

2.70

14.86

1.4

1.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

292

2.71

14.79

1.2

1.1

56.47

54.67

u/l

0.12

252

(3021601) Nitrite [Presence] in Urine by Test strip

1924

16711

1.32

14.70

4.5

3.9

0.00

estimate

0.50

481

3374

(3024932) HLA-DR beta [Type]

4.63

14.68

1.5

1.0

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1219

9935

1.34

14.58

1.8

1.7

19.45

20.22

nmol/l

1.09

1071

8313

(3024471) HLA-A [Type]

4.57

14.45

1.1

1.0

—

(3035350) Ketones [Presence] in Urine by Test strip

1943

16931

1.31

14.35

4.5

3.9

5.72

3.81

estimate

0.18

491

3454

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1111

13509

0.75

14.28

1.9

1.40

1.34

mmol/l

1.46

926

11278

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

19.19

14.21

1.4

4.0

—

(3009261) Glucose [Presence] in Urine by Test strip

1943

17022

1.30

13.37

4.5

3.9

0.02

estimate

0.27

459

3176

(3004119) Hemoglobin [Mass/volume] in Venous blood

339

2222

1.58

13.21

3.7

3.1

120.62

131.05

g/l

13.46

332

2153

(3023410) Appearance of Cerebral spinal fluid

311

2.54

13.09

2.1

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

209

2.90

13.05

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

137

697

2.00

12.82

2.0

2.7

32.23

35.24

umol/l

0.76

124

630

(3037522) Nuclear Ab [Titer] in Serum

587

4338

1.42

12.66

1.4

1.3

632.67

523.88

titre

0.52

120

968

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

372

2526

1.53

12.36

3.6

4.1

79.56

95.92

ng/l

3.31

314

2141

(3013512) EKG study

1390

11740

1.29

12.30

5.0

3.8

0.83

0.69

—

(3052851) Hemolysis interference index of Serum or Plasma

152

819

1.89

12.04

3.4

3.80

1.79

index

0.92

407

(3019060) Gas panel - Arterial blood

310

2033

1.57

12.04

5.4

4.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

262

1653

1.63

11.96

3.0

3.1

4.28

4.49

pmol/l

3.42

239

1448

(3010838) Calcium [Moles/time] in 24 hour Urine

111

538

2.10

11.87

1.8

2.1

5.23

4.81

mmol/24h

0.67

102

467

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

302

2.45

11.38

1.3

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

198

2.80

11.32

1.7

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

104

510

2.07

10.81

1.2

—

0.69

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

160

2.96

10.71

3.1

5.0

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3333

31870

1.47

10.65

25.7

10.7

26.81

25.98

u/l

1.19

3296

30704

(3043410) Blood group antigens tested for on Red Blood Cells

4.14

10.60

4.1

1.3

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

+∞

10.42

1.0

0.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

196

2.73

10.40

1.7

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

314

2138

1.51

10.28

7.3

6.5

24.59

24.53

mmol/l

0.10

297

2055

(3005322) IgE [Units/volume] in Serum or Plasma

291

1966

1.52

9.89

1.5

1.3

399.56

261.53

u/ml

0.57

246

1826

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

7.62

9.88

1.2

24.97

16.26

u/l

0.59

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

157

2.89

9.84

1.1

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

13.39

9.66

1.6

1.4

0.93

4.52

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

13.39

9.66

1.6

1.4

0.67

5.07

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

13.39

9.66

1.6

1.4

1.05

2.33

mg/l

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

7.82

9.60

1.9

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

7.82

9.60

1.9

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

7.82

9.60

1.9

1.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

333

2.25

9.60

2.9

4.0

—

(3047181) Lactate [Moles/volume] in Blood

164

973

1.72

9.50

7.0

5.5

1.44

1.34

mmol/l

0.45

140

862

(3030981) Hyaline casts [#/volume] in Urine by Automated count

378

2719

1.43

9.36

2.5

2.3

0.50

0.43

e6/l

0.29

371

2595

(3024891) Influenza virus A+B Ag [Presence] in Specimen

127

703

1.84

9.32

1.3

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

115

618

1.89

9.26

1.8

2.1

3379.85

5663.60

u/l

0.61

261

(3022145) Colonoscopy Study observation

437

3231

1.40

9.26

1.4

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

346

2.19

9.18

1.1

—

(3036603) Volume of Urine

204

2.57

9.13

1.5

1959.21

1877.52

0.29

196

(3029937) Albumin [Presence] in Urine by Test strip

1114

9420

1.26

9.07

4.8

4.1

0.01

0.00

estimate

0.49

435

3109

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

15.62

9.02

2.4

5.1

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

349

2493

1.44

8.97

3.0

2.4

61.39

64.64

ml/min/173m2

0.84

158

982

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

140

810

1.76

8.89

1.3

1.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

751

6065

1.30

8.82

1.8

1161.27

1156.96

nmol/l

0.04

596

4583

(3008295) Osmolality of Serum or Plasma

339

2.18

8.80

1.2

1.5

279.15

277.32

mosm/kgh2o

0.30

251

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.02

8.78

1.4

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

360

2601

1.43

8.69

2.3

12.04

14.91

nmol/l

9.06

336

2357

(3047189) Immunofixation for 24 hour Urine

119

3.05

8.69

1.3

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

3.73

8.60

2.2

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

140

818

1.74

8.60

1.3

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

131

2.92

8.53

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

140

825

1.72

8.35

1.3

1.2

—

(40758358) Immune stain study

+∞

8.33

1.0

0.0

—

(3052592) Norovirus Ag [Presence] in Stool

3.92

8.14

1.9

1.4

—

(3000492) Spirometry study

396

2945

1.39

8.09

1.6

1.5

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

17.19

8.07

1.0

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

131

2.84

7.94

1.1

1973.54

150.84

ng/l

0.57

(44786800) Granulocytes/Leukocytes in Body fluid

7.76

7.86

1.6

1.3

21.73

25.53

0.13

(3045424) Erythrocytes [Presence] in Urine

233

1582

1.50

7.77

2.4

2.0

0.07

0.50

estimate

0.42

509

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3347

32281

1.39

7.75

46.3

19.7

83.10

80.78

umol/l

2.78

3323

31833

(3004716) Salmonella sp identified in Stool by Organism specific culture

193

1262

1.56

7.65

1.4

1.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

127

754

1.71

7.42

1.3

1.2

1.27

3.70

u/ml

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2532

23636

1.23

7.41

4.8

4.2

15.04

14.91

pmol/l

1.94

2358

21509

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

7.29

1.0

0.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

+∞

7.29

1.0

0.0

—

(3023420) DNA double strand Ab [Units/volume] in Serum

201

1341

1.53

7.29

1.7

5.14

6.43

iu/ml

0.42

323

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

3.31

7.23

2.2

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1009

8633

1.23

7.06

4.1

3.3

0.03

0.21

estimate

0.73

397

2642

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

150

943

1.62

7.05

1.3

1.2

44.47

39.16

u/ml

0.09

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

124

743

1.69

7.02

1.1

3.08

3.44

—

(3003327) Ova and parasites identified in Stool by Light microscopy

158

1009

1.59

6.96

1.8

1.7

—

(21491868) Cryoglobulin [Mass/volume] in Serum

108

2.89

6.89

1.4

1.2

1.01

0.06

g/l

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

566

4542

1.29

6.85

1.4

1.5

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

225

1561

1.47

6.77

6.6

4.5

1.56

1.61

0.42

211

1481

(3040151) Glucose [Moles/volume] in Capillary blood

399

1.92

6.67

5.4

24.1

6.70

7.33

mmol/l

1.48

331

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

168

2.46

6.67

1.5

1.4

5.50

7.91

u/l

0.86

141

(3051611) Lipemic interference index of Serum or Plasma

283

2.10

6.65

3.2

3.5

13.13

14.03

index

0.28

145

(3024928) Oxygen saturation in Venous blood

137

865

1.61

6.36

3.2

62.05

61.46

0.11

132

834

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

143

2.53

6.26

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

128

800

1.62

6.20

1.2

1.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

205

1430

1.46

6.03

7.3

4.7

0.87

0.86

0.13

193

1357

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

139

893

1.58

6.02

1.4

1.2

2.34

2.68

u/ml

0.30

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

288

2.03

6.00

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

112

685

1.65

5.93

1.3

1.2

36.01

44.25

u/ml

0.22

(3003181) Sodium [Moles/volume] in Urine

101

601

1.70

5.93

1.4

59.38

61.64

mmol/l

0.23

486

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

320

1.95

5.77

1.1

—

25.21

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2886

30057

0.82

5.72

4.9

5.3

1.37

1.43

mmol/l

11.62

2630

27823

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

138

897

1.56

5.70

1.4

1.3

6.61

6.97

u/ml

0.04

130

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

289

2163

1.36

5.70

2.4

2.5

19.10

21.77

au/ml

0.11

188

(3044927) Protein electrophoresis panel - Urine

371

1.88

5.70

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

2.77

5.62

1.3

1.2

15.60

26.40

—

(3012516) Albumin [Mass/volume] in Urine

1062

12022

0.84

5.56

3.6

57.94

46.01

mg/l

1.01

700

7814

(40757494) Bilirubin.total [Moles/volume] in Blood

166

2.30

5.43

2.5

2.0

10.63

17.31

umol/l

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

266

1984

1.37

5.37

1.3

98.35

56.31

au/ml

1.34

137

(3000570) Elastase.pancreatic [Mass/mass] in Stool

138

911

1.53

5.34

1.5

1.4

275.74

290.30

ug/g

0.37

557

(3039162) Centromere protein B Ab [Units/volume] in Serum

395

1.81

5.29

1.3

37.37

52.58

u/ml

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1214

10811

1.18

5.27

2.2

2.3

162.81

238.19

u/l

2.99

1160

10158

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

+∞

5.21

1.0

0.0

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

+∞

5.21

1.0

0.0

—

(3007566) Smooth muscle Ab [Titer] in Serum

129

850

1.54

5.06

1.3

1.2

111.54

115.95

titre

0.05

(3034770) Mitochondria Ab [Titer] in Serum

130

859

1.53

5.03

1.2

—

1198.33

—

(3018405) Lactate [Moles/volume] in Arterial blood

162

1123

1.46

4.98

3.5

3.8

1.43

1.40

mmol/l

0.13

153

1098

(40757373) Influenza virus identified in Isolate

3.04

4.94

1.4

—

(3039000) Anion gap in Blood by calculation

103

648

1.61

4.94

9.3

6.4

11.05

11.47

mmol/l

0.60

585

(3018572) Chloride [Moles/volume] in Blood

103

648

1.61

4.94

9.3

6.4

104.40

104.81

mmol/l

0.38

585

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.67

4.90

3.0

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2821

29346

0.84

4.89

6.5

7.0

39.74

39.94

mmol/mol

0.61

2613

27368

(3026389) Candida sp identified in Specimen by Organism specific culture

384

1.79

4.86

1.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.71

4.84

1.7

1.3

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

6.49

4.77

2.3

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

910

7971

1.19

4.70

4.1

3.8

0.00

0.14

—

(3003740) Influenza virus B Ag [Presence] in Specimen

420

1.73

4.62

1.5

1.1

—

(3009508) Creatinine [Moles/volume] in Urine

1126

12537

0.85

4.61

3.4

3.5

7.13

7.56

mmol/l

2.96

933

10587

(3032057) Clostridioides difficile [Presence] in Stool

2.91

4.60

1.9

1.8

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

116

2.42

4.54

1.6

1.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

161

2.19

4.49

1.1

1.11

1.18

u/l

0.23

(3022493) Free Hemoglobin [Mass/volume] in Plasma

142

2.26

4.47

1.5

6.9

7472.00

63.76

mg/l

0.49

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.59

4.46

2.4

2.3

0.60

0.62

mmol/l

0.52

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

4.07

4.40

2.3

2.4

4924.87

5.22

ug/l

0.48

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2976

30749

0.84

4.38

5.5

6.3

2.59

2.61

mmol/l

0.89

2717

28569

(3023487) Leukocytes [#/volume] in Peritoneal fluid

2.56

4.38

1.4

2.8

3240.63

631.93

e6/l

0.54

(3002523) Influenza virus A Ag [Presence] in Specimen

420

1.70

4.36

1.5

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2923

30239

0.84

4.30

4.9

5.4

4.44

4.51

mmol/l

2.99

2687

28189

(3013945) Hepatitis B virus e Ab [Presence] in Serum

6.26

4.29

2.4

1.2

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

165

2.13

4.24

1.2

0.50

0.52

ratio

0.41

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

220

1.97

4.20

1.1

335.32

268.72

mg/l

0.69

195

(3020393) Adenovirus Ag [Presence] in Stool

4.81

4.18

1.3

1.6

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

4.81

4.18

1.4

1.1

9.93

9.58

mg/l

0.04

(3020682) Albumin/Creatinine [Ratio] in Urine

1104

12231

0.86

4.13

4.3

10.27

8.05

mg/mmol

0.88

711

7734

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

5.89

4.12

1.0

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

986

8777

1.17

4.12

3.3

2.9

0.08

0.03

0.37

259

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

2.71

4.08

1.3

2.4

16836.62

36380.86

e6/l

0.29

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1654

15302

1.15

4.05

2.2

92.99

94.94

pmol/l

0.95

973

7998

(3017704) Immunofixation for Urine

175

2.07

4.05

1.3

1.2

—

(3004451) EKG impression Narrative

210

1.96

4.01

1.2

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

111

2.35

3.99

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

3.03

3.96

1.0

—

(1761868) Lipid panel - Serum or Plasma

977

10895

0.86

3.95

3.2

3.4

—

(3014891) Appearance of Pleural fluid

3.79

3.89

1.9

1.5

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

4.30

3.81

1.8

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

468

1.62

3.80

1.1

22.73

19.36

au/ml

0.15

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1379

12644

1.14

3.77

4.6

3.9

0.01

0.10

estimate

1.04

415

2763

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

12.02

3.76

4.0

6.2

—

(3033099) Centromere Ab [Titer] in Serum

2.74

3.75

1.0

1.2

—

(4015189) Microbial culture of sputum

2.40

3.72

2.0

3.0

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2942

28429

1.17

3.63

5.8

5.2

2.10

1.97

mu/l

5.41

2747

26115

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

190

1.96

3.62

1.6

1.5

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

233

1.86

3.59

1.2

1.1

51.24

39.48

mg/l

0.50

194

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

813

7216

1.16

3.46

1.7

12757056.10

35035694.95

pmol/l

0.89

682

5954

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

115

2.18

3.28

1.3

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

8.58

3.26

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

8.58

3.26

1.0

—

(3033086) Enterovirus Ab [Titer] in Serum

8.58

3.26

1.0

—

(3026250) Tacrolimus [Mass/volume] in Blood

122

2.14

3.25

26.7

38.5

8.08

7.47

ug/l

0.99

111

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

234

1.80

3.25

1.2

112.14

104.74

pmol/l

0.39

234

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

149

2.02

3.25

1.9

1.7

1.65

3.29

u/field

0.59

100

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

3.80

3.18

5.4

7.1

40.00

42.55

ug/min

0.05

(3015171) Extractable nuclear Ab [Units/volume] in Serum

162

1222

1.34

3.16

1.4

1.2

4.45

0.75

u/ml

0.61

(3007461) Platelets [#/volume] in Blood

3352

32839

1.22

3.15

54.1

22.6

230.99

243.68

e9/l

19.36

3301

32058

(3045414) Leukocytes [Presence] in Urine

377

3157

1.22

3.14

2.3

2.0

0.10

0.01

estimate

0.86

657

(3020876) Protein [Mass/time] in 24 hour Urine

389

1.60

3.13

1.9

2.1

0.89

1.48

g/24h

1.19

218

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.25

3.12

1.1

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

3352

32843

1.22

3.12

53.9

22.5

91.65

91.29

4.62

3328

32404

(3035941) MCH [Entitic mass]

3352

32845

1.22

3.10

53.8

22.5

30.36

30.42

1.02

3328

32409

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

3352

32846

1.22

3.10

54.6

23.1

38.31

40.74

46.20

3325

32398

(3026361) Erythrocytes [#/volume] in Blood

3352

32847

1.22

3.09

54.0

22.6

4.25

4.51

e12/l

129.64

3296

31920

(3010813) Leukocytes [#/volume] in Blood

3352

32852

1.22

3.05

54.1

22.6

6.83

6.75

e9/l

0.60

3298

31912

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

211

2657

0.78

3.04

1.8

2.0

3.58

3.51

ratio

0.30

167

2096

(3000963) Hemoglobin [Mass/volume] in Blood

3352

32854

1.22

3.04

54.3

22.7

126.96

136.52

g/l

194.36

3330

32421

(3046861) Legionella sp Ag [Presence] in Urine

5.84

3.02

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

10.01

2.98

1.0

189.80

379.20

u/ml

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

404

1.57

2.93

1.9

2.1

23.46

22.94

mg/l

0.04

132

(3044242) Glucose [Moles/volume] in Arterial blood

199

1.82

2.89

1.6

8.43

8.28

mmol/l

0.09

199

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

5.39

2.87

1.6

1.0

1.00

u/field

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

345

1.60

2.82

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.47

2.78

1.4

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

2.55

2.78

1.0

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

375

3182

1.20

2.75

2.2

2.5

8.83

8.11

ug/l

0.16

329

2798

(1002224) Polysomnography panel

1296

0.71

2.73

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

6.01

2.70

1.0

1.1

—

(3005570) Glucose [Moles/volume] in Urine

319

1.61

2.66

1.5

2.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

147

1.91

2.65

1.2

1.6

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

413

0.51

2.59

1.1

1.02

1.26

u/ml

—

215

(3047007) Chlamydophila sp Ab [Presence] in Serum

378

1.54

2.56

1.1

1.3

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

7.15

2.55

1.2

1.3

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

2.73

2.54

1.2

1.1

61.67

48.60

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.23

2.51

1.0

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

549

0.58

2.50

1.2

1.1

2.46

2.13

u/ml

0.09

305

(3008401) Mugwort IgE Ab [Units/volume] in Serum

459

0.54

2.49

1.1

0.69

1.22

u/ml

—

206

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

158

1.84

2.47

1.1

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

2.67

2.45

1.8

1.6

—

(21494755) Public health laboratory ask at order entry panel

166

2085

0.79

2.40

1.3

1.4

—

(3026480) Teichoate Ab [Titer] in Serum

3.34

2.39

1.1

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

6.26

2.37

1.0

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

4.12

2.36

1.6

1.2

7041.14

2455.11

ng/l

—

(1761482) Bacteria [#/volume] in Urine by Culture

106

789

1.35

2.34

4.2

4.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.26

2.34

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

103

765

1.36

2.31

3.1

3.4

0.88

0.82

nmol/l

0.27

619

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.18

2.30

1.1

77.40

89.33

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.95

2.28

1.1

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

260

0.42

2.27

1.5

1.6

77.06

54.84

ug/l

0.55

260

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.48

2.27

2.1

3.1

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

155

1945

0.79

2.24

1.5

1.8

3.27

3.47

mmol/l

1.09

110

1375

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.13

2.18

1.1

72.80

90.74

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

696

1.36

2.17

3.6

3.8

28.40

28.45

mg/l

0.00

494

(3017569) Oxygen content in Arterial blood

211

1.67

2.16

1.6

1.8

14.08

16.59

5.18

211

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2801

28730

0.90

2.14

4.3

4.6

1.32

1.29

mmol/l

1.21

2540

26288

(3048689) Calprotectin [Mass/mass] in Stool

434

3813

1.16

2.13

2.3

2.4

183.29

145.41

ug/g

1.10

363

3027

(3003888) Timothy IgE Ab [Units/volume] in Serum

470

0.59

2.07

1.1

4.15

4.18

u/ml

0.00

254

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.50

2.05

1.4

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

110

1.91

2.05

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

107

818

1.32

2.02

1.8

1.7

262.23

293.06

mu/l

0.69

102

747

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.34

1.96

1.0

1.4

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

3.34

1.96

2.1

2.5

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.75

1.93

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.75

1.93

1.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

2.12

1.92

2.9

2.2

6.56

8.20

mmol/l

—

(3044007) Cell count panel - Peritoneal fluid

2.06

1.90

1.6

2.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1000

0.73

1.89

1.3

1.8

6.08

4.89

mg/l

0.20

729

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

365

1.46

1.88

1.2

1.3

0.19

nmol/l

0.12

307

(3050794) Legionella sp Ab [Presence] in Serum

3.19

1.88

1.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

317

0.53

1.86

1.1

0.24

u/ml

—

117

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

3.53

1.83

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.53

1.83

1.0

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.53

1.83

1.0

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

152

1.72

1.83

1.1

1341.19

1616.59

miu/ml

0.58

152

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

215

1810

1.20

1.80

1.2

85.09

128.75

u/ml

1.23

693

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.00

1.79

1.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

155

1264

1.24

1.78

2.3

2.2

443.37

707.49

ug/l

0.52

145

1198

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.17

1.77

2.0

2.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

153

0.39

1.75

1.0

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.90

1.75

7.6

2.7

5.11

5.20

kpa

0.09

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.90

1.75

7.6

2.7

9.52

9.90

kpa

0.29

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

170

1.65

1.73

2.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.96

1.69

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

105

1326

0.79

1.67

1.6

1.5

0.23

0.31

mg/l

0.96

611

(3004616) Nuclear Ab [Presence] in Serum

400

1.41

1.67

1.4

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.16

1.66

1.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.16

1.66

1.0

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

376

1.42

1.64

1.1

1.3

—

nmol/l

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

352

0.59

1.61

1.6

—

(4212803) Bone marrow aspirate examination

3.00

1.58

1.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

215

1.54

1.56

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.43

1.53

1.0

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.00

1.52

0.0

1.1

—

0.60

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3030

29753

1.10

1.50

5.5

5.95

6.04

mmol/l

3.42

2782

27164

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

154

1.63

1.49

1.1

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.23

1.46

1.0

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

878

0.76

1.46

1.3

1.2

1.49

1.51

g/l

0.23

878

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

260

1.47

1.45

2.3

2.2

1.46

1.48

u/field

0.01

145

(3002079) Sodium [Moles/time] in 24 hour Urine

140

1.65

1.44

1.2

1.3

153.57

169.85

mmol/24h

0.37

140

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.04

1.43

2.1

2.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

805

0.75

1.40

1.2

1.1

0.57

0.65

ratio

0.56

(3014133) Dog dander IgE Ab [Units/volume] in Serum

362

0.63

1.39

1.1

4.28

4.21

u/ml

0.01

181

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.94

1.36

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

618

0.72

1.35

1.7

1.4

—

(3011985) Renin [Units/volume] in Plasma

452

1.33

1.35

1.4

44.16

75.52

mu/l

0.96

402

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.04

1.32

1.0

—

(3016750) Collection duration of Urine

176

1.54

1.31

2.4

2.2

510.28

500.04

min

0.24

132

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.50

1.30

1.0

1.6

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

281

1.39

1.18

1.4

1.2

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

0.00

1.16

0.0

1.4

—

140.14

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.05

1.15

1.0

1.2

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

226

2555

0.88

1.14

1.5

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

2.34

1.12

1.6

1.1

—

mmol/l

—

(3000330) Specific gravity of Urine by Test strip

192

1678

1.15

1.12

3.7

3.3

1.02

ratio

0.08

178

1525

(3035320) C reactive protein [Mass/volume] in Body fluid

243

1.40

1.09

2.5

2.7

33.23

33.73

mg/l

0.02

177

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

256

0.62

1.09

1.2

1.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

120

1.59

1.08

1.6

1.1

40.51

39.48

g/l

0.25

120

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.19

1.08

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1307

12549

1.06

5.3

4.3

3.83

1.97

ug/l

1.78

1176

11375

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

759

1.22

1.05

1.6

1.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

472

1.28

1.04

1.3

1.2

2.72

2.78

u/ml

0.02

166

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

309

0.68

0.99

2.2

1.8

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.00

0.96

0.0

1.3

—

283.39

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

425

1.27

0.95

1.4

1.3

327.16

306.36

pmol/l

0.20

355

(3034274) Bile acid [Moles/volume] in Serum --fasting

276

1.34

0.95

1.4

2.1

5.71

6.89

umol/l

0.31

190

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

119

0.50

0.93

4.8

2.4

151.00

155.40

nmol/l

—

111

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

438

4061

1.09

0.93

10.8

6.9

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

142

1.48

0.92

1.1

1.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

772

7321

1.07

0.91

3.0

2.9

0.80

0.71

ug/l

1.48

516

4823

(3006442) Creatine [Moles/volume] in Serum or Plasma

201

1.40

0.91

1.7

1.8

105.50

88.42

umol/l

0.38

201

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

159

1.45

0.91

1.0

1.2

21.33

17.87

u/ml

—

(3050129) First trimester maternal screen panel - Serum or Plasma

486

0.76

0.91

1.3

1.4

—

(40768446) Kidney Pathology biopsy report

118

1.53

0.90

1.5

1.6

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

1.69

0.88

1.5

1.3

33.23

32.13

nmol/l

0.06

(3022621) pH of Urine by Test strip

278

2532

1.11

0.87

2.9

2.7

5.99

6.08

0.90

185

1722

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.86

0.87

1.1

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

334

0.72

0.86

1.1

2.98

4.62

u/ml

0.37

145

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

379

1.27

0.85

1.3

1.19

1.43

nmol/l

1.31

338

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.56

0.84

1.2

1.5

126.60

71.10

nmol/24h

0.72

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

741

0.82

0.80

1.5

1.6

864.29

974.70

mu/l

0.55

621

(3002619) Bacteria identified in Specimen by Culture

1.67

0.78

1.4

1.2

—

(3018333) Ribosomal P Ab [Presence] in Serum

251

1.32

0.78

1.2

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.77

0.76

2.0

3.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

200

2207

0.90

0.74

1.8

2.0

—

(3025130) Human papilloma virus identified in Specimen

316

1.27

0.73

1.8

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

220

2412

0.91

0.73

1.9

2.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.52

0.72

1.1

—

(3006462) Nitrate [Presence] in Urine

143

1.40

0.70

2.1

3.5

—

(4268621) Lupus anticoagulant assay

337

1.25

0.69

2.1

2.3

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.85

0.68

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

196

1.33

0.67

1.1

11.56

11.92

iu/ml

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

122

1084

1.13

0.64

1.8

1.9

44.07

42.04

nmol/l

0.45

122

1043

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

431

4064

1.07

0.64

4.5

5.4

31.60

32.72

1.16

294

2672

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

183

1666

1.10

0.63

2.3

2.5

—

(4034850) Laboratory test

1070

0.88

0.62

14.0

10.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

245

0.73

0.61

1.2

1.4

126.12

208.14

pmol/l

1.23

245

(3020650) Glucose [Presence] in Urine

1.46

0.61

1.2

1.9

0.00

0.09

estimate

1.08

(4211845) Urine protein measurement

156

1.35

0.61

2.1

3.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

262

1.26

0.61

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

308

1.24

0.59

1.2

—

(3003577) Lead [Moles/volume] in Blood

0.00

0.59

0.0

1.2

—

0.14

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

210

1.29

0.58

1.0

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

345

1.22

0.58

1.0

1.1

1.89

2.38

eliau/ml

0.33

134

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.58

0.0

2.2

—

1.47

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.58

0.0

2.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

465

1.19

0.57

1.3

1.2

2.25

5.35

u/ml

2.31

220

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

355

1.21

0.57

1.2

88.63

95.61

0.92

335

(3045683) HLA typing for celiac disease panel - Blood or Tissue

159

1.32

0.55

1.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

257

1.25

0.55

1.2

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

776

1.14

0.55

1.7

1.9

5.48

11.71

iu/l

0.36

299

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

168

1.31

0.55

2.3

2.0

267.00

244.02

ug/min

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.46

0.54

1.1

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.48

0.53

1.3

1.8

0.44

0.50

e9/l

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

147

0.68

0.53

2.7

2.4

50.60

54.30

umol/l

—

129

(36660697) Celiac disease serology panel - Serum

264

2468

1.08

0.53

1.1

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.43

0.52

2.3

1.8

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

462

1.17

0.51

1.6

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

269

1.23

0.51

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

269

1.23

0.51

1.2

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.46

0.50

1.0

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.46

0.50

1.3

1.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

313

0.80

0.49

1.5

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.45

0.48

1.5

1.6

1.13

1.17

mmol/l

0.77

(37208534) Antinuclear antibody arbitrary concentration in serum

102

1.37

0.47

1.1

1.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

272

1.22

0.47

1.2

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

118

1072

1.10

0.47

1.7

—

(3027944) Amphetamines [Presence] in Urine

888

0.89

0.47

1.6

2.0

—

(3028300) Cannabinoids [Presence] in Urine

898

0.89

0.46

1.6

2.0

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

282

1.21

0.46

1.1

—

(3004775) Volume in Urine collected for unspecified duration

264

1.21

0.45

2.7

2.4

854.00

635.31

1.34

173

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

256

2409

1.07

0.45

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

905

0.89

0.44

1.9

1.5

10896.32

12555.08

e6/l

0.28

640

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.37

0.44

1.0

1.1

60.24

46.85

iu/ml

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.43

0.42

1.1

1.2

—

13.60

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

736

1.12

0.42

1.0

1.1

4.15

7.40

eliau/ml

—

(3034092) Cytoplasmic Ig cells/cells in Blood

1.56

0.42

9.4

8.7

0.22

0.20

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.41

0.0

1.0

—

(3000764) Benzodiazepines [Presence] in Urine

889

0.90

0.41

1.6

2.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

983

0.90

0.41

1.6

1.4

—

(3016879) Cocaine [Presence] in Urine

836

0.89

0.40

1.6

2.1

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

0.39

0.0

11.5

—

180.43

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.39

0.0

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.39

0.0

1.1

—

(4195642) Thrombophilia screening test

429

1.14

0.38

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

139

1495

0.93

0.37

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

449

1.14

0.37

1.2

—

(3027008) Opiates [Presence] in Urine

892

0.91

0.36

1.6

2.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.29

0.36

7.1

7.3

9.21

10.41

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

122

0.74

0.35

1.3

1.6

8.83

8.45

mmol/l

—

117

(3028717) Thiamine [Mass/volume] in Blood

1.40

0.35

1.3

1.2

55.83

66.23

ug/l

—

(44813793) Dust mix specific IgE antibody measurement

211

0.80

0.34

1.1

—

(3024263) Appearance of Synovial fluid

167

0.78

0.34

2.2

1.7

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.33

0.33

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.33

0.33

1.0

1.1

—

(3034426) Prothrombin time (PT)

100

1.30

0.33

1.3

1.2

28.00

28.18

0.04

100

(3044941) Cell count panel - Synovial fluid

635

0.90

0.33

1.8

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

856

1.09

0.32

2.4

2.3

128.82

118.61

ug/min

0.10

501

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

686

0.90

0.32

1.8

1.7

1.08

0.83

nmol/l

1.83

581

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

248

1.17

0.31

1.1

1.3

2.53

1.66

u/ml

0.29

148

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

708

6909

1.03

0.30

1.3

1.36

1.80

u/ml

0.44

148

1823

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

507

1.11

0.28

1.1

2.11

397.26

iu/ml

—

105

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.27

0.27

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

211

2209

0.95

0.27

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

332

0.87

0.27

1.7

1.4

28041.95

125322.93

e6/l

1.71

228

(4133840) Spirometry

1.19

0.26

1.5

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

394

0.89

0.26

1.9

2.7

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

105

1.24

0.24

3.0

2.5

1.47

1.19

ug/l

0.19

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

142

1.20

0.24

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

363

3519

1.03

0.24

1.5

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.32

0.23

3.8

2.3

0.60

0.58

u/field

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

143

1.19

0.23

1.4

1.3

6.16

6.05

mmol/l

0.14

135

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2528

25119

1.02

0.22

44.5

19.3

330.86

332.58

g/l

19.06

2514

24973

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.04

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.4

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

2.10

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

5.2

—

380.60

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

182

1.15

0.21

1.1

1.2

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

0.00

0.21

0.0

1.3

—

315.00

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.11

—

(4198724) Urine methamphetamine measurement

105

0.76

0.21

1.9

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

697

0.93

0.20

1.6

2.0

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

0.12

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.20

0.0

1.0

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

1.21

0.19

1.8

1.2

0.33

0.31

g/l

0.30

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

203

1.13

0.19

1.3

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

120

1256

0.95

0.18

1.8

2.1

—

(4146454) Self-monitoring of blood glucose

414

0.92

0.17

3.1

2.8

—

(3039443) Prostate specific Ag panel - Serum or Plasma

620

0.93

0.17

1.7

1.6

—

(3021788) Differential panel - Synovial fluid

630

1.06

0.17

1.7

1.4

—

1.00

—

(3019150) Specific gravity of Urine by Refractometry

763

7743

0.98

0.17

4.6

4.1

1.02

1.22

kg/l

0.51

557

5038

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

101

1059

0.95

0.17

1.7

2.0

—

(3005033) Fetal Nuchal fold Thickness US

321

1.09

0.16

1.5

1.19

1.27

0.65

229

(3011288) Drugs identified in Urine by Screen method Nominal

595

0.94

0.15

1.9

3.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

0.82

0.13

2.3

1.4

14.92

17.65

pmol/l

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

452

1.06

0.13

1.2

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

292

0.92

0.11

1.0

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

199

0.90

0.11

1.8

1.4

1.58

1.23

nmol/l

0.60

148

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

172

1.11

0.11

1.3

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

271

0.92

0.11

1.5

1.4

0.54

1.26

promille

2.16

208

(3043238) Trisomy 21 risk [Likelihood] in Fetus

339

1.06

0.10

1.6

1.5

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.06

0.09

1.2

1.1

0.12

7.40

u/ml

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.04

0.09

7.0

12.1

4.96

5.44

mmol/l

—

(3013637) Mi-2 Ab [Presence] in Serum

116

1.12

0.09

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

116

1.12

0.09

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

116

1.12

0.09

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

116

1.12

0.09

1.0

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

116

1191

0.97

0.09

1.6

17.69

17.89

u/ml

0.01

234

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

1.05

0.08

1.0

1.1

33.33

54.12

u/ml

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

332

1.05

0.08

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.86

0.07

1.0

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.81

0.07

1.0

0.22

1.56

u/ml

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.82

0.07

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.12

0.06

6.7

7.1

4.73

5.14

kpa

—

(3006653) Thiamine [Moles/volume] in Blood

183

0.93

0.06

1.4

1.2

122.88

139.97

nmol/l

1.18

183

(3008898) HLA-B27 [Presence]

922

0.98

0.06

1.1

—

(3014271) Vancomycin [Susceptibility]

168

1.07

0.06

2.4

3.1

—

(4024509) Urine culture

163

1610

1.01

0.04

2.1

1.9

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

530

5330

0.99

0.04

1.2

1.3

11.17

12.97

u/ml

0.23

176

2021

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

239

1.05

0.04

1.6

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

428

1.03

0.03

1.5

63.34

61.09

ug/l

0.10

358

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

340

3423

0.99

0.03

1.7

1.8

1.48

1.51

0.29

296

2975

(3006270) Folate [Moles/volume] in Blood

280

1.04

0.03

1.1

1.2

383.00

348.82

nmol/l

0.44

234

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

112

1.07

0.03

1.0

1.2

12.33

9.01

mm/h

0.41

112

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

132

1.06

0.02

1.8

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

142

1.06

0.02

1.5

2.3

75.50

165.44

umol/l

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

291

1.03

0.02

1.0

954.30

714.41

ng/l

2.21

187

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

568

5689

1.00

0.01

1.3

40.49

35.29

iu/ml

0.33

171

1671

(4094501) Cardiovascular stress test using bicycle ergometer

943

1.01

0.01

1.1

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

106

0.94

0.01

1.5

1.3

48.97

55.94

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1016

10168

1.00

0.00

4.3

3.9

21.51

24.29

6.98

498

4861

(3036670) Protein [Mass/volume] in Synovial fluid

112

0.98

0.00

1.3

1.2

38.13

39.14

g/l

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

148

1.01

0.00

3.4

2.0

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

415

1.01

0.00

1.7

1.5

64.85

59.52

0.43

272

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

101

0.99

0.00

15.4

6.5

71.80

68.27

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

311

1.00

0.00

1.8

1.5

35.16

28.39

0.39

203

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

396

1.01

0.00

1.5

1.18

1.17

ratio

0.06

246

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.04

0.00

2.7

1.4

7.85

9.51

ug/l

—

(3000034) Microalbumin [Mass/volume] in Urine

324

0.99

0.00

2.7

3.0

22.34

31.63

mg/l

0.36

250

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

386

1.01

0.00

1.4

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

396

1.01

0.00

1.5

0.88

0.94

ratio

0.72

246

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

396

1.01

0.00

1.5

1.20

1.19

ratio

0.03

246

(44806420) Estimation of glomerular filtration rate

283

0.99

0.00

2.4

2.5

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

7.0

—

0.24

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.7

—

24.92

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

31.67

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

-0.00

0.0

1.0

—

177.40

—

(3036180) Methadone [Presence] in Urine

0.00

-0.00

0.0

2.5

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.88

-0.00

1.2

1.4

—

(3042733) HLA Ab [Presence] in Serum

0.92

-0.00

4.3

4.6

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

1.81

—

(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

25.20

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

3650.00

—

(3005067) clonazePAM [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

60.94

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

247.29

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

34.40

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.8

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

10.29

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.3

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.1

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1.01

-0.00

1.6

1.5

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_LYMPHNODES_SECONDARY_NAS – Secondary and unspecified malignant neoplasm of lymph nodes

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Secondary and unspecified malignant neoplasm of lymph nodes

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Secondary and unspecified malignant neoplasm of lymph nodes (C3_LYMPHNODES_SECONDARY_NAS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints